PRGO


Line plots across dimensions of each concept
Tables

Table of contents



us-gaap:CommonStockValue

us-gaap:CommonStockParOrStatedValuePerShare
us-gaap:StatementEquityComponents
us-gaap:SharesOutstanding

us-gaap:CommonStockSharesIssued

us-gaap:CommonStockSharesAuthorized

us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

us-gaap:WeightedAverageNumberOfSharesOutstandingBasic

us-gaap:EarningsPerShareBasic

us-gaap:EarningsPerShareDiluted

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService
us-gaap:ProductOrService, us-gaap:StatementBusinessSegments
us-gaap:StatementBusinessSegments
us-gaap:StatementGeographical

us-gaap:CostOfGoodsAndServicesSold

us-gaap:GrossProfit

us-gaap:OperatingExpenses

us-gaap:ResearchAndDevelopmentExpense

us-gaap:GeneralAndAdministrativeExpense

us-gaap:SellingAndMarketingExpense

us-gaap:OperatingIncomeLoss
us-gaap:StatementBusinessSegments

us-gaap:OtherNonoperatingIncomeExpense

us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic

us-gaap:IncomeTaxExpenseBenefit

us-gaap:ComprehensiveIncomeNetOfTax

us-gaap:NetIncomeLoss
us-gaap:StatementEquityComponents

us-gaap:Assets
us-gaap:StatementBusinessSegments

us-gaap:Liabilities

us-gaap:LiabilitiesAndStockholdersEquity

us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents

us-gaap:AssetsCurrent

us-gaap:CashAndCashEquivalentsAtCarryingValue

us-gaap:AccountsReceivableNetCurrent

us-gaap:InventoryNet

us-gaap:InventoryFinishedGoods

us-gaap:PrepaidExpenseAndOtherAssetsCurrent

us-gaap:PropertyPlantAndEquipmentNet

us-gaap:Goodwill
us-gaap:BusinessAcquisition, us-gaap:StatementBusinessSegments
us-gaap:StatementBusinessSegments

us-gaap:IntangibleAssetsNetExcludingGoodwill

us-gaap:FiniteLivedIntangibleAssetsNet

us-gaap:OtherAssetsNoncurrent

us-gaap:LiabilitiesCurrent

us-gaap:DebtCurrent

us-gaap:LongTermDebtCurrent

us-gaap:AccountsPayableCurrent

us-gaap:AccruedIncomeTaxesCurrent

us-gaap:LiabilitiesNoncurrent
us-gaap:DebtInstrument, us-gaap:FairValueByFairValueHierarchyLevel
us-gaap:LongTermDebt
us-gaap:DebtInstrument, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementBasis

us-gaap:LongTermDebtNoncurrent

us-gaap:MinorityInterest

us-gaap:OtherLiabilitiesNoncurrent

us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents

us-gaap:CommonStockValue

us-gaap:RetainedEarningsAccumulatedDeficit

us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax

us-gaap:NetCashProvidedByUsedInOperatingActivities

us-gaap:NetCashProvidedByUsedInInvestingActivities

us-gaap:NetCashProvidedByUsedInFinancingActivities

us-gaap:NetCashProvidedByUsedInOperatingActivities

us-gaap:NetIncomeLoss
us-gaap:StatementEquityComponents

us-gaap:DepreciationDepletionAndAmortization

us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet

us-gaap:IncreaseDecreaseInInventories

us-gaap:NetCashProvidedByUsedInInvestingActivities

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

us-gaap:NetCashProvidedByUsedInFinancingActivities

us-gaap:RepaymentsOfLongTermDebt

us-gaap:PaymentsOfDividends

us-gaap:PaymentsOfDividends

us-gaap:RepaymentsOfLongTermDebt
us-gaap:DebtInstrument
us-gaap:DebtInstrumentInterestRateStatedPercentage

us-gaap:EffectiveIncomeTaxRateContinuingOperations

us-gaap:ShareBasedCompensation

us-gaap:OperatingLeaseRightOfUseAsset
us-gaap:BalanceSheetLocation
us-gaap:StatementBusinessSegments

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

prgo:CashFlowHedgeGainLossReclassifiedtoEarningsNet

prgo:ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent
us-gaap:FinancialInstrument, us-gaap:MeasurementInputType, us-gaap:ValuationTechnique
prgo:ContingentConsiderationPaymentsSalesbasedMilestonesPercent
us-gaap:CounterpartyName
prgo:FairValueAssumptionVolatility
us-gaap:CounterpartyName
prgo:FairValueAssumptionsRateofReturn

prgo:FinanceLeaseCost
us-gaap:IncomeTaxAuthority, us-gaap:IncomeTaxAuthorityName, us-gaap:StatementScenario
prgo:ForeignStatutoryCorporateTaxRate

prgo:IncreaseDecreaseInAccruedCustomerPrograms
us-gaap:LitigationCase
prgo:LossContingencyNumberofLawsuits
us-gaap:LitigationCase, us-gaap:SubsequentEventType

prgo:OtherOperatingIncomeLoss

prgo:ProceedsfromContingentMilestonePayment

prgo:ProceedsfromRoyaltiesReceivedInvestingActivities

prgo:RestructuringAdditionalCharges

us-gaap:AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities

us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
us-gaap:StatementEquityComponents

us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
us-gaap:StatementEquityComponents

us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
us-gaap:StatementEquityComponents

us-gaap:AmortizationOfDebtDiscountPremium

us-gaap:AmortizationOfIntangibleAssets
us-gaap:StatementBusinessSegments

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount

us-gaap:AssetImpairmentCharges

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect

us-gaap:CommonStockDividendsPerShareDeclared

us-gaap:DeferredIncomeTaxExpenseBenefit
us-gaap:DerivativeInstrumentRisk, us-gaap:HedgingDesignation, us-gaap:IncomeStatementLocation
us-gaap:DerivativeGainLossOnDerivativeNet
us-gaap:HedgingDesignation

us-gaap:DividendsCommonStockCash
us-gaap:StatementEquityComponents

us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
us-gaap:IncomeStatementLocation
us-gaap:EquitySecuritiesFvNiGainLoss
us-gaap:FairValueByAssetClass, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
us-gaap:FairValueByAssetClass, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements

us-gaap:FairValueOptionChangesInFairValueGainLoss1

us-gaap:FinanceLeaseInterestExpense

us-gaap:FinanceLeaseInterestPaymentOnLiability

us-gaap:FinanceLeasePrincipalPayments

us-gaap:FinanceLeaseRightOfUseAssetAmortization
us-gaap:BusinessAcquisition, us-gaap:FiniteLivedIntangibleAssetsByMajorClass
us-gaap:FinitelivedIntangibleAssetsAcquired1
us-gaap:IncomeStatementLocation
us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet

us-gaap:GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet
us-gaap:IncomeStatementLocation
us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness

us-gaap:GoodwillForeignCurrencyTranslationGainLoss
us-gaap:StatementBusinessSegments

us-gaap:GoodwillPurchaseAccountingAdjustments
us-gaap:StatementBusinessSegments
us-gaap:IncomeStatementLocation
us-gaap:IncomeLossFromEquityMethodInvestments

us-gaap:IncreaseDecreaseInAccountsPayable

us-gaap:IncreaseDecreaseInAccountsReceivable

us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable

us-gaap:IncreaseDecreaseInAccruedLiabilities

us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities

us-gaap:IncreaseDecreaseInOperatingCapital

us-gaap:IncreaseDecreaseInPrepaidExpense

us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements

us-gaap:InterestIncomeExpenseNet

us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
us-gaap:StatementEquityComponents

us-gaap:OperatingLeaseCost

us-gaap:OperatingLeasePayments

us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent

us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent

us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent

us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
us-gaap:DerivativeInstrumentRisk

us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
us-gaap:StatementEquityComponents

us-gaap:OtherOperatingActivitiesCashFlowStatement

us-gaap:PaymentsForProceedsFromOtherInvestingActivities

us-gaap:PaymentsForRestructuring
us-gaap:BusinessAcquisition
us-gaap:PaymentsToAcquireBusinessesGross
us-gaap:BusinessAcquisition, us-gaap:StatementBusinessSegments, us-gaap:SubsequentEventType
us-gaap:BusinessAcquisition, us-gaap:SubsequentEventType

us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired

us-gaap:PaymentsToAcquireOtherProductiveAssets

us-gaap:ProceedsFromPaymentsForOtherFinancingActivities

us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess

us-gaap:ProductionAndDistributionCosts

us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
us-gaap:StatementEquityComponents

us-gaap:RestructuringCharges

us-gaap:RestructuringReserveSettledWithoutCash2

us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability

us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
us-gaap:StatementEquityComponents
us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures

prgo:AccruedCustomerPrograms
us-gaap:FairValueByAssetClass, us-gaap:StatementScenario
prgo:AssetAdjustedFairValueifSalesThresholdMet
us-gaap:StatementScenario
us-gaap:StatementScenario, us-gaap:FairValueByAssetClass
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
prgo:FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure

prgo:GoodwillAndIndefiniteLivedIntangibles

prgo:LeaseLiabilities
us-gaap:LitigationCase
prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals
us-gaap:LitigationCase, us-gaap:SubsequentEventType
us-gaap:LitigationCase
prgo:LossContingencyNumberOfOptOutCases
us-gaap:LitigationCase, us-gaap:SubsequentEventType
us-gaap:LitigationCase
prgo:LossContingencyNumberofCodefendants
us-gaap:LitigationCase, us-gaap:SubsequentEventType
us-gaap:LitigationCase
prgo:NumberofCaseswithSimilarFactualAllegations
us-gaap:LitigationCase, us-gaap:SubsequentEventType
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
prgo:PotentialContingentMilestonePayments
us-gaap:StatementScenario

prgo:RightofUseAsset

us-gaap:AccruedLiabilitiesCurrent

us-gaap:AllowanceForDoubtfulAccountsReceivable
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:AssetsFairValueDisclosure

us-gaap:AssetsNoncurrent
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:BusinessCombinationContingentConsiderationLiability

us-gaap:ContractWithCustomerAssetGrossCurrent

us-gaap:DebtInstrumentFeeAmount

us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet

us-gaap:DebtLongtermAndShorttermCombinedAmount

us-gaap:DeferredIncomeTaxAssetsNet

us-gaap:DeferredIncomeTaxLiabilitiesNet
us-gaap:BalanceSheetLocation, us-gaap:DerivativeInstrumentRisk, us-gaap:HedgingDesignation
us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
us-gaap:HedgingDesignation
us-gaap:BalanceSheetLocation, us-gaap:DerivativeInstrumentRisk, us-gaap:HedgingDesignation
us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
us-gaap:Currency, us-gaap:DerivativeInstrumentRisk
us-gaap:DerivativeNotionalAmount
us-gaap:DerivativeInstrumentRisk

us-gaap:EmployeeRelatedLiabilitiesCurrent
us-gaap:BalanceSheetLocation
us-gaap:EquityMethodInvestments
us-gaap:BalanceSheetLocation
us-gaap:EquitySecuritiesFvNi
us-gaap:FairValueByAssetClass, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue

us-gaap:FinanceLeaseLiability
us-gaap:StatementBusinessSegments
us-gaap:BalanceSheetLocation
us-gaap:FinanceLeaseLiabilityCurrent
us-gaap:BalanceSheetLocation
us-gaap:FinanceLeaseLiabilityNoncurrent

us-gaap:FinanceLeaseRightOfUseAsset
us-gaap:BalanceSheetLocation
us-gaap:StatementBusinessSegments

us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
us-gaap:FiniteLivedIntangibleAssetsByMajorClass
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure

us-gaap:FiniteLivedIntangibleAssetsGross
us-gaap:FiniteLivedIntangibleAssetsByMajorClass
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:GoodwillFairValueDisclosure

us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
us-gaap:IndefiniteLivedIntangibleAssetsByMajorClass

us-gaap:InventoryRawMaterials

us-gaap:InventoryWorkInProcess
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:InvestmentsFairValueDisclosure
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:LiabilitiesFairValueDisclosure
us-gaap:DebtInstrument
us-gaap:LineOfCredit

us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding
us-gaap:DebtInstrument
us-gaap:LoansPayable

us-gaap:OperatingLeaseLiability
us-gaap:StatementBusinessSegments
us-gaap:BalanceSheetLocation
us-gaap:OperatingLeaseLiabilityCurrent
us-gaap:BalanceSheetLocation
us-gaap:OperatingLeaseLiabilityNoncurrent

us-gaap:OtherLongTermDebt

us-gaap:PreferredStockParOrStatedValuePerShare

us-gaap:RestructuringReserve

us-gaap:SeniorNotes
us-gaap:DebtInstrument
us-gaap:DebtInstrument, us-gaap:FairValueByFairValueHierarchyLevel
us-gaap:DebtInstrument, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementBasis

us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Tables

  2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-302012-12-292012-09-29
us-gaap:CommonStockValue ▇▇▇▇▇▇▇▇▇▇▇██████████▇▇▆▆▆▆▁▁73397359737873957409742174367594776978927900804481188135813581518144816081448632862177047695668566786670666200NANANA
us-gaap:CommonStockParOrStatedValuePerShare ▁▁▁▁▁▁▁▁▁▁▁▁▁▁▁▁▁▁▁▁▁▁▁▁▁▁▁██0.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.00.00.050.05NANANA
 us-gaap:SharesOutstanding us-gaap:StatementEquityComponents us-gaap:CommonStock▂▂▂▂▂▁▁▄▇█136136136136136135135137139140NANANA143143NANANA143NA146NANANA133NANANA94NANANA
us-gaap:CommonStockSharesIssued █████▇▇████████████████▇▇▇▇▁▁13613613613613613513513713914014014214314314314314314314314614614014013313313313300NANANA
us-gaap:CommonStockSharesAuthorized ███████████████████████████▁▁10000100001000010000100001000010000100001000010000100001000010000100001000010000100001000010000100001000010000100001000010000100001000020002000NANANA
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding ▇▇▇▇▇▇▇▇▇▇▇██████████▇▇▆▆▆▂▁▁▁▁▁137137136136136136137138141141141143143143143143143143144146146140136134134134989494949494
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic ▇▇▇▇▇▇▇▇▇▇▇██████████▇▇▆▆▆▂▁▁▁▁▁136136136136135135137138140140141143143143143143143143144146146140136133133133989494949393
us-gaap:EarningsPerShareBasic █▇█▇▇█▇▇▇▇▇▇▇▁▁▁█▆▇█▇▇▇██▇▇█████0.78-0.140.680.070.470.6-0.490.260.570.520.31-0.490.5-9.48-9.48-8.761.36-2.34-0.740.770.39-0.670.520.720.980.36-0.871.181.261.191.131.13
us-gaap:EarningsPerShareDiluted █▇█▇▇█▇▇▇▇▇▇▇▁▁▁█▆▇█▇▇▇██▇▇█████0.77-0.140.670.070.470.6-0.490.260.570.520.31-0.490.5-9.48-9.48-8.761.35-2.34-0.740.770.38-0.670.510.720.980.36-0.871.181.251.181.121.12
  2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-302012-12-292012-09-29
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax ▆▆▅▄▅▅▄▅▅▆▅▅▅▆▆▆█▇▆▆█▄▄▃▄▃▃▃▃▂▂▁1341132211911149117411951133118612171283123112371194133113311354148113831359134415311049107195111441004979933967919883769
 us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:ProductOrService,us-gaap:StatementBusinessSegments prgo:UpperRespiratory,prgo:ConsumerSelfCareAmericas154NANANA132NANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:StatementBusinessSegments prgo:ConsumerSelfCareAmericas▇█▃▁▁▃▂▂▂700710613582581616596596601NANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:StatementBusinessSegments prgo:ConsumerSelfCareInternational█▅▄▁▄▁▂▅▇382356347327350329334357377NANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:StatementBusinessSegments prgo:RXPharmaceuticals█▇▅▆▆▅▁▃▆█▇▆257255230239241222179208237261250240NANANANANANANANANANANANANANANANANANANANA
 us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:StatementGeographical country:US██▃▂▂▄▁▂▃901902785768768800739772786NANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:StatementGeographical srt:Europe█▅▃▁▄▂▁▅▇372344334315340324317344361NANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:CostOfGoodsAndServicesSold █▇▄▁▂▃▁▁▂▄▂▂▂857842778718725752708715724770733733729NANA848913860757795903670687629728689618577611588575NA
us-gaap:GrossProfit ▅▅▄▄▄▄▄▅▅▆▅▅▅▅▅▆▇▆▇▆█▃▃▂▄▂▃▂▂▂▁▁483480412430448443424471492512497504464487487506567522559548628378383321415315360356356331307285
us-gaap:OperatingExpenses ▁▆▂▂▁▁█▂▁▂▁▂▁337487358375346335546376336354335355335NANA2021328826653360401179199184218211274176176152143NA
us-gaap:ResearchAndDevelopmentExpense ▁▄▂▂▁▂▂█▁▂▁▂▁41594443404443913846384239NANA50474546416235533638443732312828NA
us-gaap:GeneralAndAdministrativeExpense ▆▅▇▇▆▆▃▁▃█▆▁▃1221181311271251251059610713412398105NANA108101106185123140798481978115478646260NA
us-gaap:SellingAndMarketingExpense ▄▄▁▃▅▄▁▆█▄▃▆▆147144134140148144134155161144143155155NANA15417118015816717448445058524750564943NA
us-gaap:OperatingIncomeLoss █▄▅▅▇▇▁▆████▇145-65455102107-12294156158162148128NANA-1515238-303-9418822619918413719710386179180178163NA
 us-gaap:OperatingIncomeLoss us-gaap:StatementBusinessSegments prgo:ConsumerSelfCareAmericas██▇▇▇▇▁▆█1241308110794110-11964118NANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:OperatingIncomeLoss us-gaap:StatementBusinessSegments prgo:ConsumerSelfCareInternational█▂▅▁▄▁▁▃▅25113-28-4-4412NANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:OperatingIncomeLoss us-gaap:StatementBusinessSegments prgo:RXPharmaceuticals▇▁▆▆██▇██51-9219146067365661NA826988NANA74NANANANANANANANANANANANANANANANA
us-gaap:OtherNonoperatingIncomeExpense ▁▂█▁▁▂▂▁▁▂▂▁▂-2071-2-360-7-493-63NANA-1-29-3-12-13-22-258-59-2-5-1-4-1000NA
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic █▁█▇▇▄▆▇███▆█114-505972780-195-7955110131128-7695NANA-1571151-359-155132157-102NANANANANANANANANANA
us-gaap:IncomeTaxExpenseBenefit ▂▁▂▃▃█▁▃▃▅▆▁▃8-1551817122-1119295884-624NANA-316-42-24-4819101-714123314-2745434839NA
us-gaap:ComprehensiveIncomeNetOfTax ▄▆▅▅▅▅▂▁██▇▆▇26349394822-79-13315313510587127NANA-121588-182-18775177-12133114163-75138108118140NA
us-gaap:NetIncomeLoss █▇█▇▇▇▇▇▇▇▇▇▇▁▁▁█▆▇█▇▇▇██▇▇█████106-199296381-6736807344-6971-1359-1359-1255194-334-10711256-94709613148-86111118111106105
 us-gaap:NetIncomeLoss us-gaap:StatementEquityComponents us-gaap:RetainedEarnings106NA92963NA-673680NANANANANANANANANANANANANANANANANANANANANANANA
  2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-302012-12-292012-09-29
us-gaap:Assets ▅▅▅▅▅▅▅▅▅▅▅▅▆▆▆▇█████▇▇▆▆▆▆▁▁114001130111310114281111910983109421122511639116281184211792139791387013870174671953319726193931970319720161821646013781138801374213712130NANANA
 us-gaap:Assets us-gaap:StatementBusinessSegments prgo:ConsumerSelfCareAmericas█▆▆▆▃▁417939903989404137043571NANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:Assets us-gaap:StatementBusinessSegments prgo:ConsumerSelfCareInternational▆█▁▁▂▃465346824589459345974613NANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:Assets us-gaap:StatementBusinessSegments prgo:RXPharmaceuticals▁▃▆▇█▇▅▆▇█▂25682628273227932817279826992753276628132597NANA26462646NANANANANANANANANANANANANANANANANA
us-gaap:Liabilities ▂▂▂▂▂▁▁▁▂▂▂▂▅▅▅▆██▇▇▇▃▃▁▁5613549755515702541853155282532854345458580057117912791279128796963398799357897190576597674550645186NANANA3018NANANA
us-gaap:LiabilitiesAndStockholdersEquity ▅▅▅▅▅▅▅▅▅▅▅▅▆▆▆▇█████▇▇▆▆▆▆▁▁114001130111310114281111910983109421122511639116281184211792139791387013870174671953319726193931970319720161821646013781138801374213712130NANANA
us-gaap:StockholdersEquity ▁▁▁▁▁▁▁▁▂▂▂▂▂▁▁▅▇▇▇██▆▇▅▅▅▅578658035758572657005668565958976205617060416081606759585958867199009847100361073210662958597158716869285588500NA2331NANANA
 us-gaap:StockholdersEquity us-gaap:StatementEquityComponents us-gaap:CommonStock▁▁▁▂▂▂▂▄▆█7339735973787395740974217436759477697892NANANA81358135NANANA8144NA8621NANANA6678NANANA538NANANA
  2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-302012-12-292012-09-29
us-gaap:AssetsCurrent ▅▅▅▅▅▅▅▅▅▅▅▅█▅▅▄▅▅▅▅▅██▄▄▄▄▁▁30462756273934353009290227682778290028192971282151132805280526273032297427442880318251305364263425502304228640NANANA
us-gaap:CashAndCashEquivalentsAtCarryingValue ▂▂▂▃▃▂▂▂▂▂▃▂▇▂▂▂▂▂▂▂▃██▃▃▂▂▁▁510354398105583755144452668767877576030776226223626415884175067853430359689179960952100NA459NA
us-gaap:AccountsReceivableNetCurrent █▇▅▆▆▅▅▆▆▆▅▅▅▆▆▆▇▇▇▇█▂▃▂▃▁▁129612431102111711181073107911291123113010761065105011761176112911991184119312321282881924869935793769NA651NANANA
us-gaap:InventoryNet ▇██▇▆▆▆▆▅▄▅▅▄▄▄▆▆▆▅▆▅▁▁▁▁▂▂930967990940912878885883843806821818800795795884894868844888838637641656631693702NA703NANANA
us-gaap:InventoryFinishedGoods ▅██▆▄▂▄▅▃▃▄▃▂▁▁▆▇▆▄▆▃485530536501474444473485467454471467449431431511523506483504468NANANA307NANANANANANANA
us-gaap:PrepaidExpenseAndOtherAssetsCurrent ▆▄▅▇▃█▇▅▅▅▆▄▄▅▅▅▆▇▆▄▃▃▃▃▃▂▂▁▁30819224832213940035923824620329717618521221225029733228916814189115130116606600NANANA
  2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-302012-12-292012-09-29
us-gaap:PropertyPlantAndEquipmentNet ▇▇▆▄▄▅▄▄▅▅▄▆▆▆▆▆▇▇▆██▃▂▂▃▂▁889902871824821829820811829833822876875870870881888896886924932769756761779740718NA681NANANA
us-gaap:Goodwill ▄▄▄▃▄▄▄▄▄▄▄▄▄▄▄▅███▇▇▂▂▂▂▁▁409041164222393539663979399441374209417541524150407640494049449052715281536449874971340334163436347432073187NA1089NANANA
 us-gaap:Goodwill us-gaap:StatementBusinessSegments prgo:ConsumerSelfCareAmericas▆▇█▁▂▂188218991943167317141713NANANA1847NANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:Goodwill us-gaap:StatementBusinessSegments prgo:ConsumerSelfCareInternational▇█▃▂▁▃119612031157114211331151NANANA1205NANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:Goodwill us-gaap:StatementBusinessSegments prgo:RXPharmaceuticals▁▁████████▆10101013112211191117111411171117112211221093NANA10861086NANANA1084NA1086NANANANANANANANANANANA
us-gaap:IntangibleAssetsNetExcludingGoodwill ▁▁▁▁▁▁▁▁▁▁▁▁▁▁▁▇█████▄▄▄▄4752475346334360437944284465467648234752472446764561453145311093011668117561142811853114237496750374417463NANANA1558NANANA
us-gaap:FiniteLivedIntangibleAssetsNet ▁▁▁▁▁▁▁▁▂▂▂▂▂▂▂███▇█▇▅▆▆▆▆▆287729212899267527572858295930663259329033473373334133963396834086798519819082908105652766376671678771817223NA1157NANANA
us-gaap:OtherAssetsNoncurrent ▅▇▇▇▇▆▆▆▆▇██▇▃▃▃▃▃▃▃▃▄▂▂▂▁▁311399396383382362351341330409423435394211211206205225237225225260191182195155139NA76NANANA
  2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-302012-12-292012-09-29
us-gaap:LiabilitiesCurrent ▆▅▅▆▆▅▅▅▅▅▆▆█▆▆▅▇▇█▆▆▅▅▄▄▄▄▁▁1635133513241790183115371493153713921436173216292485183618361540209320892490166116931284132510171074953961130NANANA
us-gaap:DebtCurrent ▅▁▁▇█▄▄▄▂▂287333984671901941975870NANANA572572NANANANANA1060NANANANANANANANANANANA
us-gaap:LongTermDebtCurrent ▃▁▁▃▄▂▂▂▁▁▃▃█▄▄▃▆▅▇▁▁▃▃▂▂▂▂287333984671901941975870417406117557257226575861910185858355362141141141141NA41NANANA
us-gaap:AccountsPayableCurrent ▅▄▄▄▅▄▄▅▄▃▄▄▄▄▄▄▄▅▅▅█▁▁▁▂▁▁555520524513549474503533512450477480476471471507514559554541747323302309364325306NA382NANANA
us-gaap:AccruedIncomeTaxesCurrent ▂▂▄▅▄▅▃▃▄▆▃▁▃▂▂▄▄█▄▄▃▁▂▂▂▁▁263277104859656576511661057323276721798582524293117104NA11NANANA
  2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-302012-12-292012-09-29
us-gaap:LiabilitiesNoncurrent ▅▅▅▅▄▄▄▄▅▅▅▅▆▆▆███▇██▆▆▅▅▅▅▁▁397841614227391135863777378937904041402240684081542660766076725675407790686773097364531254204046411142314249160NANANA
 us-gaap:LongTermDebt us-gaap:DebtInstrument,us-gaap:FairValueByFairValueHierarchyLevel prgo:PrivatePlacementNote,us-gaap:FairValueInputsLevel2▁█153168NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:LongTermDebt us-gaap:DebtInstrument,us-gaap:FairValueByFairValueHierarchyLevel,us-gaap:FairValueByMeasurementBasis prgo:PrivatePlacementNote,us-gaap:FairValueInputsLevel2,us-gaap:CarryingReportedAmountFairValueDisclosure▁█150151NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:LongTermDebtNoncurrent ▂▂▂▂▁▂▂▂▂▂▂▂▅▆▆▇▇█▆▇▇▅▅▂▂▂▂318233653361308427493052307130853280327032753267461852245224563856525902497152295246436744393050309031253159NA1927NANANA
us-gaap:MinorityInterest ▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄000000000000000000000000000NA1NANANA
us-gaap:OtherLiabilitiesNoncurrent ▇▇███▅▅▅▅▅▅▆▆▆▆▆▅▅▃▄▄▂▂▂▂▂▁509515551546554443423414428429434445458461461448414400332374372300291286293275244NA213NANANA
  2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-302012-12-292012-09-29
us-gaap:StockholdersEquity ▁▁▁▁▁▁▁▁▂▂▂▂▂▁▁▅▇▇▇██▆▇▅▅▅▅578658035758572657005668565958976205617060416081606759585958867199009847100361073210662958597158716869285588500NA2331NANANA
 us-gaap:StockholdersEquity us-gaap:StatementEquityComponents us-gaap:CommonStock▁▁▁▂▂▂▂▄▆█7339735973787395740974217436759477697892NANANA81358135NANANA8144NA8621NANANA6678NANANA538NANANA
us-gaap:CommonStockValue ▇▇▇▇▇▇▇▇▇▇▇██████████▇▇▆▆▆▆▁▁73397359737873957409742174367594776978927900804481188135813581518144816081448632862177047695668566786670666200NANANA
us-gaap:RetainedEarningsAccumulatedDeficit ▂▂▂▂▂▁▁▁▁▁▁▁▁▁▁▅▇▇████████▇▅▅-1589-1695-1676-1768-1777-1838-1919-1852-1888-1975-2049-2094-2024-2095-20954491725154919072034193819002012195718751757172300NANANA
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax ▃▅▃▄▄▄▅▅█▇▆▅▂▁▁▄▃▅▂▄▄▂▃▄▅▅▄▂▂3513956996984143155324253191130-26-81-817131136-1565102-19774139130114-160NANANA
  2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-302012-12-292012-09-29
us-gaap:NetCashProvidedByUsedInOperatingActivities ▆▂▅▁▂▇▅▂▆█▇17189140639419414482172216196NA194NANANANA17018713646226827219529218012198173150NANA
us-gaap:NetCashProvidedByUsedInInvestingActivities ▆▅▁▆█▆▆▆▆▇▆-74-106-651-68230-46-51-27-266-9NA2287NANANANA-452-425-448-2156-334-125-30-59-46-1563-35-285-296NANA
us-gaap:NetCashProvidedByUsedInFinancingActivities ▆▅▄█▅▅▃▃▄▁▃64-31-144219-41-34-175-199-162-383-172NA-37NANANANA44914943-953-312570-61-46-471151-28585-5NANA
  2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-302012-12-292012-09-29
us-gaap:NetCashProvidedByUsedInOperatingActivities ▆▂▅▁▂▇▅▂▆█▇17189140639419414482172216196NA194NANANANA17018713646226827219529218012198173150NANA
us-gaap:NetIncomeLoss █▇█▇▇▇▇▇▇▇▇▇▇▁▁▁█▆▇█▇▇▇██▇▇█████106-199296381-6736807344-6971-1359-1359-1255194-334-10711256-94709613148-86111118111106105
 us-gaap:NetIncomeLoss us-gaap:StatementEquityComponents us-gaap:RetainedEarnings106NA92963NA-673680NANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:DepreciationDepletionAndAmortization ▁▅▄▁▂▃▆▇▇██93103102949699106108109111112NA109NANANANA18215217516712712712612112762474742NANA
us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet ▅▂▅▂▂▅▄▁█▅▁6-114-10-94-1-16228-16NA26NANANANA25-16-12412-37-1218-23-14NANA
us-gaap:IncreaseDecreaseInInventories ▁▃▄▇▇▄▄█▇▃▆-36-1104037-225543-1223NA0NANANANA141357-26-2-1229-63-9-22121336NANA
  2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-302012-12-292012-09-29
us-gaap:NetCashProvidedByUsedInInvestingActivities ▆▅▁▆█▆▆▆▆▇▆-74-106-651-68230-46-51-27-266-9NA2287NANANANA-452-425-448-2156-334-125-30-59-46-1563-35-285-296NANA
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment ▅█▆▅▃█▃▂▁▅▂3347353321452319133318NA22NANANANA34393857311631514237404024NANA
  2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-302012-12-292012-09-29
us-gaap:NetCashProvidedByUsedInFinancingActivities ▆▅▄█▅▅▃▃▄▁▃64-31-144219-41-34-175-199-162-383-172NA-37NANANANA44914943-953-312570-61-46-471151-28585-5NANA
us-gaap:RepaymentsOfLongTermDebt ▁▁▆▃▁▁▁▁█▇▁003171461212121244436714NA13NANANANA141414875138953935351965000NANA
us-gaap:PaymentsOfDividends █▆▆▆▄▄▄▄▄▁▁3028282825262526262222NA23NANANANA2018181817141414149888NANA
us-gaap:PaymentsOfDividends █▆▆▆▄▄▄▄▄▁▁3028282825262526262222NA23NANANANA2018181817141414149888NANA
  2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-302012-12-292012-09-29
us-gaap:RepaymentsOfLongTermDebt ▁▁▆▃▁▁▁▁█▇▁003171461212121244436714NA13NANANANA141414875138953935351965000NANA
 us-gaap:DebtInstrumentInterestRateStatedPercentage us-gaap:DebtInstrument prgo:A4.375seniornotedueMarch152026▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄0.043750.043750.043750.043750.043750.043750.043750.043750.043750.043750.043750.043750.043750.043750.04375NA0.04375NA0.04375NANANANANANANANANANANANANA

Common Stock Value

us-gaap:CommonStockValue



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-29
Value7339735973787395740974217436759477697892790080448118813581518144816081448632862177047695668566786670666200
Percentage of CommonStockValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets64.465.165.264.766.667.668.067.766.867.966.768.258.158.746.741.741.442.043.843.747.646.748.548.148.548.60.0100.0

Common Stock Par Or Stated Value Per Share

us-gaap:CommonStockParOrStatedValuePerShare



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-29
Value0.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.00.00.050.05
Percentage of CommonStockParOrStatedValuePerShare100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.0100.0100.0

Shares Outstanding

us-gaap:StatementEquityComponents

us-gaap:SharesOutstanding

us-gaap:CommonStock



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312016-12-312015-12-312015-06-272014-06-282013-06-292012-06-302011-06-25
Value136136136136136135135137139140143143146133949392
Percentage of SharesOutstanding100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Common Stock Shares Issued

us-gaap:CommonStockSharesIssued



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-29
Value13613613613613613513513713914014014214314314314314314314614614014013313313313300
Percentage of CommonStockSharesIssued100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Common Stock Shares Outstanding

Common Stock Shares Authorized

us-gaap:CommonStockSharesAuthorized



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-29
Value100001000010000100001000010000100001000010000100001000010000100001000010000100001000010000100001000010000100001000010000100001000020002000
Percentage of CommonStockSharesAuthorized100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Weighted Average Number Of Diluted Shares Outstanding

us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-302012-12-292012-09-29
Value137137136136136136137138141141141143143143143143143143144146146140136134134134989494949494
Percentage of WeightedAverageNumberOfDilutedSharesOutstanding100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Weighted Average Number Of Shares Outstanding Basic

us-gaap:WeightedAverageNumberOfSharesOutstandingBasic



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-302012-12-292012-09-29
Value136136136136135135137138140140141143143143143143143143144146146140136133133133989494949393
Percentage of WeightedAverageNumberOfSharesOutstandingBasic100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Earnings Per Share Basic

us-gaap:EarningsPerShareBasic



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-302012-12-292012-09-29
Value0.78-0.140.680.070.470.6-0.490.260.570.520.31-0.490.5-9.48-9.48-8.761.36-2.34-0.740.770.39-0.670.520.720.980.36-0.871.181.261.191.131.13
Percentage of EarningsPerShareBasic100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Earnings Per Share Diluted

us-gaap:EarningsPerShareDiluted



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-302012-12-292012-09-29
Value0.77-0.140.670.070.470.6-0.490.260.570.520.31-0.490.5-9.48-9.48-8.761.35-2.34-0.740.770.38-0.670.510.720.980.36-0.871.181.251.181.121.12
Percentage of EarningsPerShareDiluted100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Income Loss From Continuing Operations Per Basic Share

Income Loss From Continuing Operations Per Diluted Share

Revenue From Contract With Customer Excluding Assessed Tax

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-302012-12-292012-09-29
Value1341132211911149117411951133118612171283123112371194133113311354148113831359134415311049107195111441004979933967919883769
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ProductOrService

prgo:ContractManufacturing



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-31
Value497973656768857769
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.76.06.25.75.75.77.66.55.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.76.06.25.75.75.77.66.55.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax prgo:ContractManufacturing100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ProductOrService, us-gaap:StatementBusinessSegments

prgo:AnimalHealth, prgo:ConsumerSelfCareAmericas



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-31
Value001221915203126
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.0-0.00.21.91.71.31.82.72.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.0-0.00.21.91.71.31.82.72.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax prgo:AnimalHealth prgo:ConsumerSelfCareAmericas0.0100.0100.0100.0100.0100.0100.0100.0100.0

prgo:DigestiveHealth, prgo:ConsumerSelfCareAmericas



Period End2020-03-282019-03-30
Value106102
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax8.08.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax8.08.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax prgo:DigestiveHealth prgo:ConsumerSelfCareAmericas100.0100.0

prgo:DigestiveHealth, prgo:ConsumerSelfCareInternational



Period End2020-03-282019-03-30
Value67
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.40.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.40.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax prgo:DigestiveHealth prgo:ConsumerSelfCareInternational100.0100.0

prgo:HealthyLifestyle, prgo:ConsumerSelfCareAmericas



Period End2020-03-282019-03-30
Value8576
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax6.46.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax6.46.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax prgo:HealthyLifestyle prgo:ConsumerSelfCareAmericas100.0100.0

prgo:HealthyLifestyle, prgo:ConsumerSelfCareInternational



Period End2020-03-282019-03-30
Value4347
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.34.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.34.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax prgo:HealthyLifestyle prgo:ConsumerSelfCareInternational100.0100.0

prgo:Nutrition, prgo:ConsumerSelfCareAmericas



Period End2020-03-282019-03-30
Value10299
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax7.68.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax7.68.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax prgo:Nutrition prgo:ConsumerSelfCareAmericas100.0100.0

prgo:OralSelfcare, prgo:ConsumerSelfCareAmericas



Period End2020-03-282019-03-30
Value550
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax4.10.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax4.10.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax prgo:OralSelfcare prgo:ConsumerSelfCareAmericas100.00.0

prgo:OralSelfcare, prgo:ConsumerSelfCareInternational



Period End2020-03-282019-03-30
Value231
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.70.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.70.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax prgo:OralSelfcare prgo:ConsumerSelfCareInternational100.0100.0

prgo:OtherCSCA, prgo:ConsumerSelfCareAmericas



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-30
Value22-17489788-1537975
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.7-13.27.56.80.7-12.97.06.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.7-13.27.56.80.7-12.97.06.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax prgo:OtherCSCA prgo:ConsumerSelfCareAmericas100.0100.0100.0100.0100.0100.0100.0100.0

prgo:OtherCSCI, prgo:ConsumerSelfCareInternational



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-30
Value35-1445513414649
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.7-1.13.84.53.00.24.14.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.7-1.13.84.53.00.24.14.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax prgo:OtherCSCI prgo:ConsumerSelfCareInternational100.0100.0100.0100.0100.0100.0100.0100.0

prgo:PainandSleepaids, prgo:ConsumerSelfCareAmericas



Period End2020-03-282019-03-30
Value12091
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax9.07.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax9.07.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax prgo:PainandSleepaids prgo:ConsumerSelfCareAmericas100.0100.0

prgo:PainandSleepaids, prgo:ConsumerSelfCareInternational



Period End2020-03-282019-03-30
Value4640
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.53.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.53.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax prgo:PainandSleepaids prgo:ConsumerSelfCareInternational100.0100.0

prgo:SkincareandPersonalHygiene, prgo:ConsumerSelfCareAmericas



Period End2020-03-282019-03-30
Value4645
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.53.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.53.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax prgo:SkincareandPersonalHygiene prgo:ConsumerSelfCareAmericas100.0100.0

prgo:SkincareandPersonalHygiene, prgo:ConsumerSelfCareInternational



Period End2020-03-282019-03-30
Value94101
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax7.18.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax7.18.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax prgo:SkincareandPersonalHygiene prgo:ConsumerSelfCareInternational100.0100.0

prgo:UpperRespiratory, prgo:ConsumerSelfCareAmericas



Period End2020-03-282019-03-30
Value154132
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax11.511.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax11.511.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax prgo:UpperRespiratory prgo:ConsumerSelfCareAmericas100.0100.0

prgo:UpperRespiratory, prgo:ConsumerSelfCareInternational



Period End2020-03-282019-03-30
Value8471
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax6.36.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax6.36.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax prgo:UpperRespiratory prgo:ConsumerSelfCareInternational100.0100.0

prgo:VitaminsMineralsandSupplements, prgo:ConsumerSelfCareAmericas



Period End2020-03-282019-03-30
Value66
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.50.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.50.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax prgo:VitaminsMineralsandSupplements prgo:ConsumerSelfCareAmericas100.0100.0

prgo:VitaminsMineralsandSupplements, prgo:ConsumerSelfCareInternational



Period End2020-03-282019-03-30
Value4845
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.63.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.63.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax prgo:VitaminsMineralsandSupplements prgo:ConsumerSelfCareInternational100.0100.0

us-gaap:StatementBusinessSegments

prgo:ConsumerSelfCareAmericas



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-31
Value700710613582581616596596601
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax52.253.751.550.749.551.652.650.349.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax52.253.751.550.749.551.652.650.349.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax prgo:ConsumerSelfCareAmericas100.0100.0100.0100.0100.0100.0100.0100.0100.0

prgo:ConsumerSelfCareInternational



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-31
Value382356347327350329334357377
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax28.526.929.228.529.927.629.530.231.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax28.526.929.228.529.927.629.530.231.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax prgo:ConsumerSelfCareInternational100.0100.0100.0100.0100.0100.0100.0100.0100.0

prgo:RXPharmaceuticals



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-01
Value257255230239241222179208237261250240
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax19.219.319.320.820.618.615.817.619.520.420.419.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax19.219.319.320.820.618.615.817.619.520.420.419.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax prgo:RXPharmaceuticals100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:StatementGeographical

country:IE



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-31
Value365655955
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.30.50.40.60.40.50.90.40.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.30.50.40.60.40.50.90.40.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax country:IE100.0100.0100.0100.0100.0100.0100.0100.0100.0

country:US



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-31
Value901902785768768800739772786
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax67.268.266.066.965.567.065.265.164.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax67.268.266.066.965.567.065.265.164.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0

prgo:OtherGeographicalAreas



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-31
Value667570646470766968
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax5.05.75.95.65.55.96.85.95.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax5.05.75.95.65.55.96.85.95.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax prgo:OtherGeographicalAreas100.0100.0100.0100.0100.0100.0100.0100.0100.0

srt:Europe



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-31
Value372344334315340324317344361
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax27.826.028.127.529.027.128.029.029.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax27.826.028.127.529.027.128.029.029.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax srt:Europe100.0100.0100.0100.0100.0100.0100.0100.0100.0

Revenue From Contract With Customer Including Assessed Tax

Sales Revenue Net

Sales Revenue Goods Net

Cost Of Goods And Services Sold

us-gaap:CostOfGoodsAndServicesSold



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-302012-12-29
Value857842778718725752708715724770733733729848913860757795903670687629728689618577611588575
Percentage of CostOfGoodsAndServicesSold100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax64.063.765.362.561.862.962.560.359.560.059.659.261.162.661.762.255.759.259.063.964.266.263.768.663.261.863.264.065.2

Cost Of Goods Sold

Gross Profit

us-gaap:GrossProfit



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-302012-12-292012-09-29
Value483480412430448443424471492512497504464487487506567522559548628378383321415315360356356331307285
Percentage of GrossProfit100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax36.036.434.737.538.237.137.539.740.540.040.440.838.936.636.637.438.337.841.240.841.036.135.833.836.331.436.838.236.836.034.837.1

Operating Expenses

us-gaap:OperatingExpenses



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-302012-12-29
Value3374873583753463355463763363543353553352021328826653360401179199184218211274176176152143
Percentage of OperatingExpenses100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax25.236.930.132.729.528.148.331.727.627.627.228.728.1149.222.259.848.126.826.217.118.619.419.121.128.018.918.216.616.2

Research And Development Expense

us-gaap:ResearchAndDevelopmentExpense



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-302012-12-29
Value4159444340444391384638423950474546416235533638443732312828
Percentage of ResearchAndDevelopmentExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.14.53.73.83.43.73.97.73.23.73.13.43.33.73.23.33.43.14.13.45.03.83.34.53.83.53.23.13.2

General And Administrative Expense

us-gaap:GeneralAndAdministrativeExpense



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-302012-12-29
Value1221181311271251251059610713412398105108101106185123140798481978115478646260
Percentage of GeneralAndAdministrativeExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax9.19.011.111.110.710.59.38.28.810.510.07.98.88.06.97.713.69.29.17.67.88.68.58.115.88.46.66.86.8

Selling And Marketing Expense

us-gaap:SellingAndMarketingExpense



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-302012-12-29
Value14714413414014814413415516114414315515515417118015816717448445058524750564943
Percentage of SellingAndMarketingExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax11.010.911.312.212.712.111.913.113.311.211.712.613.011.411.613.111.612.511.44.74.25.35.15.24.85.45.85.34.9

Operating Income Loss

us-gaap:OperatingIncomeLoss



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-302012-12-29
Value145-65455102107-12294156158162148128-1515238-303-9418822619918413719710386179180178163
Percentage of OperatingIncomeLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax10.9-0.54.64.88.79.0-10.88.012.812.413.212.010.8-111.816.1-22.0-6.914.014.819.017.214.417.310.38.819.318.619.418.6

us-gaap:StatementBusinessSegments

prgo:ConsumerSelfCareAmericas



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-31
Value1241308110794110-11964118
Percentage of OperatingIncomeLoss85.5-1894.2149.4196.092.1102.597.568.275.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax9.39.96.89.48.09.2-10.55.49.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax prgo:ConsumerSelfCareAmericas17.818.413.318.516.217.9-20.010.819.7

prgo:ConsumerSelfCareInternational



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-31
Value25113-28-4-4412
Percentage of OperatingIncomeLoss17.2-17.424.3-5.37.9-4.53.94.27.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.90.11.1-0.30.7-0.4-0.40.31.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax prgo:ConsumerSelfCareInternational6.50.33.8-0.92.3-1.5-1.41.13.3

prgo:RXPharmaceuticals



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-09-302017-07-012017-04-012016-10-01
Value51-921914606736566182698874
Percentage of OperatingIncomeLoss35.51339.136.226.759.263.1-29.560.139.650.646.668.6-4.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.9-7.01.71.35.25.73.24.85.16.75.67.45.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax prgo:RXPharmaceuticals20.1-36.18.66.125.130.520.127.326.132.828.80.00.0

us-gaap:MaterialReconcilingItems



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-302012-12-29
Value-55-46-59-64-60-59-32-25-33-53-48-32-40-30-20-29-111-39-50-21-25-24-23-18-106-24-6-11-8
Percentage of OperatingIncomeLoss-38.2672.5-109.9-117.5-59.2-55.326.3-26.6-21.5-34.0-29.7-22.0-31.62.0-8.49.6118.7-20.8-22.4-10.6-13.8-17.7-12.0-17.9-122.9-13.7-3.8-6.2-4.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-4.1-3.5-5.0-5.6-5.2-5.0-2.8-2.1-2.8-4.2-3.9-2.6-3.4-2.3-1.4-2.1-8.2-2.9-3.3-2.0-2.4-2.6-2.1-1.8-10.9-2.6-0.7-1.2-0.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:MaterialReconcilingItems0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Other Nonoperating Income Expense

us-gaap:OtherNonoperatingIncomeExpense



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-302012-12-29
Value-2071-2-360-7-493-63-1-29-3-12-13-22-258-59-2-5-1-4-1000
Percentage of OtherNonoperatingIncomeExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-0.20.06.0-0.2-0.30.5-0.0-0.7-0.40.70.3-0.50.3-0.1-2.0-0.3-0.9-1.0-1.5-24.6-5.5-0.3-0.5-0.2-0.4-0.1-0.0-0.1-0.0

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest

Income Loss From Continuing Operations Before Income Taxes Domestic

us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-28
Value114-505972780-195-7955110131128-7695-1571151-359-155132157-102
Percentage of IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax8.6-38.28.22.36.9-16.4-7.04.79.110.310.5-6.28.0-116.010.2-26.0-11.49.810.3-9.8

Income Loss From Continuing Operations Before Income Taxes Foreign

Income Tax Expense Benefit

us-gaap:IncomeTaxExpenseBenefit



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-302012-12-29
Value8-1551817122-1119295884-624-316-42-24-4819101-714123314-2745434839
Percentage of IncomeTaxExpenseBenefit100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.6-1.10.41.61.410.2-1.01.62.44.66.8-0.52.0-23.3-2.9-1.8-3.61.56.6-0.71.41.33.01.5-2.84.94.45.24.5

Profit Loss

Comprehensive Income Net Of Tax

us-gaap:ComprehensiveIncomeNetOfTax



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-302012-12-29
Value26349394822-79-13315313510587127-121588-182-18775177-12133114163-75138108118140
Percentage of ComprehensiveIncomeNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.24.84.13.44.11.9-7.0-11.212.610.58.57.010.6-89.76.0-13.2-13.85.611.6-11.60.33.312.36.4-7.714.911.212.915.9

Net Income Loss

us-gaap:NetIncomeLoss



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-302012-12-292012-09-29
Value106-199296381-6736807344-6971-1359-1359-1255194-334-10711256-94709613148-86111118111106105
Percentage of NetIncomeLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax7.9-1.47.70.85.46.8-6.03.16.65.73.6-5.66.0-102.1-102.1-92.613.1-24.2-7.98.43.7-9.06.610.111.54.8-8.811.912.312.212.013.7

us-gaap:StatementEquityComponents

us-gaap:RetainedEarnings



Period End2020-03-282019-09-282019-06-292019-03-302018-09-292018-06-302018-03-31
Value10692963-673680
Percentage of NetIncomeLoss100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax7.97.70.85.4-6.03.16.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:RetainedEarnings0.00.00.00.00.00.00.0

Assets

us-gaap:Assets



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-29
Value1140011301113101142811119109831094211225116391162811842117921397913870174671953319726193931970319720161821646013781138801374213712130
Percentage of Assets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:StatementBusinessSegments

prgo:ConsumerSelfCareAmericas



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-31
Value417939903989404137043571
Percentage of Assets36.735.335.335.433.332.5
Percentage of Assets36.735.335.335.433.332.5
Percentage of Assets prgo:ConsumerSelfCareAmericas100.0100.0100.0100.0100.0100.0

prgo:ConsumerSelfCareInternational



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-31
Value465346824589459345974613
Percentage of Assets40.841.440.640.241.342.0
Percentage of Assets40.841.440.640.241.342.0
Percentage of Assets prgo:ConsumerSelfCareInternational100.0100.0100.0100.0100.0100.0

prgo:RXPharmaceuticals



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302016-12-31
Value256826282732279328172798269927532766281325972646
Percentage of Assets22.523.324.224.425.325.524.724.523.824.221.919.1
Percentage of Assets22.523.324.224.425.325.524.724.523.824.221.919.1
Percentage of Assets prgo:RXPharmaceuticals100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Liabilities

us-gaap:Liabilities



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282013-06-29
Value5613549755515702541853155282532854345458580057117912791287969633987993578971905765976745506451863018
Percentage of Liabilities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets49.248.649.149.948.748.448.347.546.746.949.048.456.657.050.449.350.148.345.545.940.841.036.737.42303969465.6

Liabilities And Stockholders Equity

us-gaap:LiabilitiesAndStockholdersEquity



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-29
Value1140011301113101142811119109831094211225116391162811842117921397913870174671953319726193931970319720161821646013781138801374213712130
Percentage of LiabilitiesAndStockholdersEquity100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Stockholders Equity

us-gaap:StockholdersEquity



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-06-292012-06-302011-06-25
Value57865803575857265700566856595897620561706041608160675958867199009847100361073210662958597158716869285588500233118511529
Percentage of StockholdersEquity100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets50.851.450.950.151.351.651.752.553.353.151.051.643.443.049.650.749.951.854.554.159.259.063.362.662.362.01779694656.50.00.0

us-gaap:StatementEquityComponents

us-gaap:AccumulatedDefinedBenefitPlansAdjustment



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312016-12-312015-12-312015-06-27
Value-8-6-5-4-4-40011-9-2-8
Percentage of StockholdersEquity-0.1-0.1-0.1-0.1-0.1-0.1-0.00.00.00.0-0.2-0.0-0.1
Percentage of Assets-0.1-0.1-0.0-0.0-0.0-0.0-0.00.00.00.0-0.1-0.0-0.0
Percentage of Assets us-gaap:AccumulatedDefinedBenefitPlansAdjustment0.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedges



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312016-12-312015-12-312015-06-27
Value31220-11-13-15-14-13-10-9-19-14-16
Percentage of StockholdersEquity0.10.20.4-0.2-0.2-0.3-0.3-0.2-0.2-0.2-0.3-0.1-0.2
Percentage of Assets0.00.10.2-0.1-0.1-0.1-0.1-0.1-0.1-0.1-0.1-0.1-0.1
Percentage of Assets us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedges0.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AccumulatedOtherComprehensiveIncome



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312016-12-312015-12-312015-06-272014-06-282013-06-292012-06-302011-06-25
Value3513956996984143155324253-81-151021397739127
Percentage of StockholdersEquity0.62.41.01.71.21.52.52.65.24.1-1.4-0.21.01.63.32.18.3
Percentage of Assets0.31.20.50.90.60.81.31.42.82.2-0.6-0.10.51.058778626.00.00.0
Percentage of Assets us-gaap:AccumulatedOtherComprehensiveIncome0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AccumulatedTranslationAdjustment



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312016-12-312015-12-312015-06-27
Value401324111587104158168333260-67-4130
Percentage of StockholdersEquity0.72.30.72.01.51.82.82.85.44.2-1.1-0.01.2
Percentage of Assets0.41.20.41.00.81.01.41.52.92.2-0.5-0.00.7
Percentage of Assets us-gaap:AccumulatedTranslationAdjustment0.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:CommonStock



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312016-12-312015-12-312015-06-272014-06-282013-06-292012-06-302011-06-25
Value73397359737873957409742174367594776978928135814486216678538504467
Percentage of StockholdersEquity126.8126.8128.1129.2130.0130.9131.4128.8125.2127.9136.581.180.976.823.127.330.6
Percentage of Assets64.465.165.264.766.667.668.067.766.867.958.742.043.748.1411068702.30.00.0
Percentage of Assets us-gaap:CommonStock0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:RetainedEarnings



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312016-12-312015-12-312015-06-272014-06-282013-06-292012-06-302011-06-25
Value-1589-1695-1676-1768-1777-1838-1919-1852-1888-1975-209519071938187517151306934
Percentage of StockholdersEquity-27.5-29.2-29.1-30.9-31.2-32.4-33.9-31.4-30.4-32.0-35.219.018.221.673.670.661.1
Percentage of Assets-13.9-15.0-14.8-15.5-16.0-16.7-17.5-16.5-16.2-17.0-15.19.89.813.51309847328.20.00.0
Percentage of Assets us-gaap:RetainedEarnings0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Assets Current

us-gaap:AssetsCurrent



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-29
Value3046275627393435300929022768277829002819297128215113280526273032297427442880318251305364263425502304228640
Percentage of AssetsCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets26.724.424.230.127.126.425.324.824.924.225.123.936.620.215.015.515.114.214.616.131.732.619.118.416.816.736.0100.0

Cash And Cash Equivalents At Carrying Value

us-gaap:CashAndCashEquivalentsAtCarryingValue



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292012-12-292012-06-302011-06-25
Value510354398105583755144452668767877576030776223626415884175067853430359689179960952100459602310
Percentage of CashAndCashEquivalentsAtCarryingValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets4.53.13.59.27.55.04.14.75.95.86.66.522.04.52.13.33.02.22.64.021.221.86.55.84.43.80.0100.00.00.00.0

Accounts Receivable Net Current

us-gaap:AccountsReceivableNetCurrent



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-06-29
Value12961243110211171118107310791129112311301076106510501176112911991184119312321282881924869935793769651
Percentage of AccountsReceivableNetCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets11.411.09.79.810.19.89.910.19.79.79.19.07.58.56.56.16.06.26.36.55.45.66.36.75.85.6497633587.8

Inventory Net

us-gaap:InventoryNet



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-06-29
Value930967990940912878885883843806821818800795884894868844888838637641656631693702703
Percentage of InventoryNet100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets8.28.68.88.28.28.08.17.97.26.96.96.95.75.75.14.64.44.44.54.33.93.94.84.65.05.1537328244.3

Inventory Finished Goods

us-gaap:InventoryFinishedGoods



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272014-06-28
Value485530536501474444473485467454471467449431511523506483504468307
Percentage of InventoryFinishedGoods100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets4.34.74.74.44.34.14.34.34.03.94.04.03.23.12.92.72.62.52.62.42.2

Prepaid Expense And Other Assets Current

us-gaap:PrepaidExpenseAndOtherAssetsCurrent



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-29
Value30819224832213940035923824620329717618521225029733228916814189115130116606600
Percentage of PrepaidExpenseAndOtherAssetsCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0
Percentage of Assets2.71.72.22.81.33.63.32.12.11.72.51.51.31.51.41.51.71.50.90.70.60.70.90.80.40.50.20.0

Land

Machinery And Equipment Gross

Property Plant And Equipment Gross

Accumulated Depreciation Depletion And Amortization Property Plant And Equipment

Property Plant And Equipment Net

us-gaap:PropertyPlantAndEquipmentNet



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-06-292012-06-30
Value889902871824821829820811829833822876875870881888896886924932769756761779740718681578
Percentage of PropertyPlantAndEquipmentNet100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets7.88.07.77.27.47.57.57.27.17.26.97.46.36.35.04.54.54.64.74.74.84.65.55.65.45.2520152671.80.0

Goodwill

us-gaap:Goodwill



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022016-03-012015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-06-292012-06-30
Value4090411642223935396639793994413742094175415241504076404944905271528105364498749713403341634363474320731871089777
Percentage of Goodwill100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets35.936.437.334.435.736.236.536.936.235.935.135.229.229.225.727.026.80.027.725.325.221.020.824.925.023.323.2831526717.60.0

us-gaap:BusinessAcquisition, us-gaap:StatementBusinessSegments

prgo:RanirGlobalHoldingsLLC, prgo:ConsumerSelfCareAmericas



Period End2020-03-282019-12-312019-09-28
Value212223269
Percentage of Goodwill5.25.46.4
Percentage of Assets1.92.02.4
Percentage of Assets prgo:RanirGlobalHoldingsLLC prgo:ConsumerSelfCareAmericas0.00.00.0

prgo:RanirGlobalHoldingsLLC, prgo:ConsumerSelfCareInternational



Period End2020-03-282019-12-312019-09-28
Value786857
Percentage of Goodwill1.91.71.4
Percentage of Assets0.70.60.5
Percentage of Assets prgo:RanirGlobalHoldingsLLC prgo:ConsumerSelfCareInternational0.00.00.0

us-gaap:StatementBusinessSegments

prgo:ConsumerSelfCareAmericas



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312017-12-31
Value1882189919431673171417131847
Percentage of Goodwill46.046.146.042.543.243.144.2
Percentage of Assets16.516.817.214.615.415.615.9
Percentage of Assets prgo:ConsumerSelfCareAmericas45.047.648.741.446.348.00.0

prgo:ConsumerSelfCareInternational



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312017-12-31
Value1196120311571142113311511205
Percentage of Goodwill29.329.227.429.028.628.928.9
Percentage of Assets10.510.710.210.010.210.510.4
Percentage of Assets prgo:ConsumerSelfCareInternational25.725.725.224.924.725.00.0

prgo:RXPharmaceuticals



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302016-12-312015-12-312015-06-27
Value10101013112211191117111411171117112211221093108610841086
Percentage of Goodwill24.724.626.628.528.228.028.027.026.726.926.326.820.221.8
Percentage of Assets8.99.09.99.810.110.110.210.09.69.79.27.85.65.5
Percentage of Assets prgo:RXPharmaceuticals39.438.641.140.139.739.841.440.640.639.942.141.10.00.0

Intangible Assets Net Excluding Goodwill

us-gaap:IntangibleAssetsNetExcludingGoodwill



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282013-06-29
Value4752475346334360437944284465467648234752472446764561453110930116681175611428118531142374967503744174631558
Percentage of IntangibleAssetsNetExcludingGoodwill100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets41.742.141.038.139.440.340.841.741.440.939.939.732.632.762.659.759.658.960.257.946.345.654.053.81189694656.5

Finite Lived Intangible Assets Net

us-gaap:FiniteLivedIntangibleAssetsNet



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-06-29
Value287729212899267527572858295930663259329033473373334133968340867985198190829081056527663766716787718172231157
Percentage of FiniteLivedIntangibleAssetsNet100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets25.225.825.623.424.826.027.027.328.028.328.328.623.924.547.844.443.242.242.141.140.340.348.448.952.352.7883664122.1

Deferred Tax Assets Liabilities Net

Other Assets Noncurrent

us-gaap:OtherAssetsNoncurrent



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-06-29
Value31139939638338236235134133040942343539421120620522523722522526019118219515513976
Percentage of OtherAssetsNoncurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets2.73.53.53.43.43.33.23.02.83.53.63.72.81.51.21.11.11.21.11.11.61.21.31.41.11.058091603.1

Liabilities Current

us-gaap:LiabilitiesCurrent



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-29
Value163513351324179018311537149315371392143617321629248518361540209320892490166116931284132510171074953961130
Percentage of LiabilitiesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0
Percentage of Assets14.311.811.715.716.514.013.613.712.012.314.613.817.813.28.810.710.612.88.48.67.98.07.47.76.97.0101.50.0

Debt Current

us-gaap:DebtCurrent



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312016-12-312015-06-27
Value2873339846719019419758705721060
Percentage of DebtCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets2.50.00.03.54.21.71.81.80.50.64.15.4

Long Term Debt Current

us-gaap:LongTermDebtCurrent



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-06-29
Value28733398467190194197587041740611755722657586191018585835536214114114114141
Percentage of LongTermDebtCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets2.50.00.03.54.21.71.81.80.50.63.53.58.44.11.53.93.15.30.30.32.22.21.01.01.01.031450381.7

Accounts Payable Current

us-gaap:AccountsPayableCurrent



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-06-29
Value555520524513549474503533512450477480476471507514559554541747323302309364325306382
Percentage of AccountsPayableCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets4.94.64.64.54.94.34.64.84.43.94.04.13.43.42.92.62.82.92.73.82.01.82.22.62.42.2291603053.4

Accrued Income Taxes Current

us-gaap:AccruedIncomeTaxesCurrent



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-06-29
Value263277104859656576511661057327672179858252429311710411
Percentage of AccruedIncomeTaxesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.20.30.70.90.80.90.50.50.61.00.50.00.40.20.40.40.90.40.40.30.00.20.20.10.10.08854961.8

Liabilities Noncurrent

us-gaap:LiabilitiesNoncurrent



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-29
Value39784161422739113586377737893790404140224068408154266076725675407790686773097364531254204046411142314249160
Percentage of LiabilitiesNoncurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0
Percentage of Assets34.936.837.434.232.334.434.633.834.734.634.434.638.843.841.538.639.535.437.137.332.832.929.429.630.831.0125.70.0

Long Term Debt

us-gaap:DebtInstrument, us-gaap:FairValueByFairValueHierarchyLevel

us-gaap:LongTermDebt

prgo:PrivatePlacementNote, us-gaap:FairValueInputsLevel2



Period End2020-03-282019-12-31
Value153168
Percentage of LongTermDebt100.0100.0
Percentage of Assets1.31.5
Percentage of Assets prgo:PrivatePlacementNote us-gaap:FairValueInputsLevel20.00.0

us-gaap:DebtInstrument, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementBasis

prgo:PrivatePlacementNote, us-gaap:FairValueInputsLevel2, us-gaap:CarryingReportedAmountFairValueDisclosure



Period End2020-03-282019-12-31
Value150151
Percentage of LongTermDebt98.089.9
Percentage of Assets1.31.3
Percentage of Assets prgo:PrivatePlacementNote us-gaap:FairValueInputsLevel2 us-gaap:CarryingReportedAmountFairValueDisclosure0.00.0

Long Term Debt Noncurrent

us-gaap:LongTermDebtNoncurrent



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-06-29
Value318233653361308427493052307130853280327032753267461852245638565259024971522952464367443930503090312531591927
Percentage of LongTermDebtNoncurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets27.929.829.727.024.727.828.127.528.228.127.727.733.037.732.328.929.925.626.526.627.027.022.122.322.723.01471603053.4

Deferred Tax Liabilities Noncurrent

Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent

Minority Interest

us-gaap:MinorityInterest



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-06-29
Value000000000000000000000000001
Percentage of MinorityInterest100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.00.0100.00.00.00.0100.0100.0100.0100.0
Percentage of Assets0.00.00.00.00.00.00.00.00.00.00.00.0-0.0-0.0-0.0-0.0-0.0-0.00.00.00.00.00.00.00.00.0916030.5

Other Liabilities Noncurrent

us-gaap:OtherLiabilitiesNoncurrent



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-06-29
Value509515551546554443423414428429434445458461448414400332374372300291286293275244213
Percentage of OtherLiabilitiesNoncurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets4.54.64.94.85.04.03.93.73.73.73.73.83.33.32.62.12.01.71.91.91.91.82.12.12.01.8162748091.6

Stockholders Equity

us-gaap:StockholdersEquity



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-06-292012-06-302011-06-25
Value57865803575857265700566856595897620561706041608160675958867199009847100361073210662958597158716869285588500233118511529
Percentage of StockholdersEquity100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets50.851.450.950.151.351.651.752.553.353.151.051.643.443.049.650.749.951.854.554.159.259.063.362.662.362.01779694656.50.00.0

us-gaap:StatementEquityComponents

us-gaap:AccumulatedDefinedBenefitPlansAdjustment



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312016-12-312015-12-312015-06-27
Value-8-6-5-4-4-40011-9-2-8
Percentage of StockholdersEquity-0.1-0.1-0.1-0.1-0.1-0.1-0.00.00.00.0-0.2-0.0-0.1
Percentage of Assets-0.1-0.1-0.0-0.0-0.0-0.0-0.00.00.00.0-0.1-0.0-0.0
Percentage of Assets us-gaap:AccumulatedDefinedBenefitPlansAdjustment0.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedges



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312016-12-312015-12-312015-06-27
Value31220-11-13-15-14-13-10-9-19-14-16
Percentage of StockholdersEquity0.10.20.4-0.2-0.2-0.3-0.3-0.2-0.2-0.2-0.3-0.1-0.2
Percentage of Assets0.00.10.2-0.1-0.1-0.1-0.1-0.1-0.1-0.1-0.1-0.1-0.1
Percentage of Assets us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedges0.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AccumulatedOtherComprehensiveIncome



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312016-12-312015-12-312015-06-272014-06-282013-06-292012-06-302011-06-25
Value3513956996984143155324253-81-151021397739127
Percentage of StockholdersEquity0.62.41.01.71.21.52.52.65.24.1-1.4-0.21.01.63.32.18.3
Percentage of Assets0.31.20.50.90.60.81.31.42.82.2-0.6-0.10.51.058778626.00.00.0
Percentage of Assets us-gaap:AccumulatedOtherComprehensiveIncome0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AccumulatedTranslationAdjustment



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312016-12-312015-12-312015-06-27
Value401324111587104158168333260-67-4130
Percentage of StockholdersEquity0.72.30.72.01.51.82.82.85.44.2-1.1-0.01.2
Percentage of Assets0.41.20.41.00.81.01.41.52.92.2-0.5-0.00.7
Percentage of Assets us-gaap:AccumulatedTranslationAdjustment0.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:CommonStock



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312016-12-312015-12-312015-06-272014-06-282013-06-292012-06-302011-06-25
Value73397359737873957409742174367594776978928135814486216678538504467
Percentage of StockholdersEquity126.8126.8128.1129.2130.0130.9131.4128.8125.2127.9136.581.180.976.823.127.330.6
Percentage of Assets64.465.165.264.766.667.668.067.766.867.958.742.043.748.1411068702.30.00.0
Percentage of Assets us-gaap:CommonStock0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:RetainedEarnings



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312016-12-312015-12-312015-06-272014-06-282013-06-292012-06-302011-06-25
Value-1589-1695-1676-1768-1777-1838-1919-1852-1888-1975-209519071938187517151306934
Percentage of StockholdersEquity-27.5-29.2-29.1-30.9-31.2-32.4-33.9-31.4-30.4-32.0-35.219.018.221.673.670.661.1
Percentage of Assets-13.9-15.0-14.8-15.5-16.0-16.7-17.5-16.5-16.2-17.0-15.19.89.813.51309847328.20.00.0
Percentage of Assets us-gaap:RetainedEarnings0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Common Stock Value

us-gaap:CommonStockValue



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-29
Value7339735973787395740974217436759477697892790080448118813581518144816081448632862177047695668566786670666200
Percentage of CommonStockValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets64.465.165.264.766.667.668.067.766.867.966.768.258.158.746.741.741.442.043.843.747.646.748.548.148.548.60.0100.0

Retained Earnings Accumulated Deficit

us-gaap:RetainedEarningsAccumulatedDeficit



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-29
Value-1589-1695-1676-1768-1777-1838-1919-1852-1888-1975-2049-2094-2024-20954491725154919072034193819002012195718751757172300
Percentage of RetainedEarningsAccumulatedDeficit100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0
Percentage of Assets-13.9-15.0-14.8-15.5-16.0-16.7-17.5-16.5-16.2-17.0-17.3-17.8-14.5-15.12.68.87.99.810.39.811.712.214.213.512.812.6-1.50.0

Accumulated Other Comprehensive Income Loss Net Of Tax

us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292012-06-30
Value3513956996984143155324253191130-26-817131136-1565102-19774139130114-16039
Percentage of AccumulatedOtherComprehensiveIncomeLossNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0
Percentage of Assets0.31.20.50.90.60.81.31.42.82.21.61.1-0.2-0.60.40.20.7-0.10.30.5-0.10.00.51.00.90.8-125.70.00.0

Net Cash Provided By Used In Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-04-012016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-30
Value1718914063941941448217221619619417018713646226827219529218012198173150
Percentage of NetCashProvidedByUsedInOperatingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax12.86.811.85.68.016.312.76.914.216.916.016.312.313.810.130.225.525.420.525.618.012.410.618.016.4

Net Cash Provided By Used In Investing Activities

us-gaap:NetCashProvidedByUsedInInvestingActivities



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-04-012016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-30
Value-74-106-651-68230-46-51-27-266-92287-452-425-448-2156-334-125-30-59-46-1563-35-285-296
Percentage of NetCashProvidedByUsedInInvestingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-5.6-8.0-54.7-5.919.6-3.9-4.5-2.3-0.25.1-0.8191.6-32.7-31.3-33.4-140.8-31.8-11.7-3.2-5.2-4.6-159.7-3.8-29.5-32.2

Net Cash Provided By Used In Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-04-012016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-30
Value64-31-144219-41-34-175-199-162-383-172-3744914943-953-312570-61-46-471151-28585-5
Percentage of NetCashProvidedByUsedInFinancingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax4.8-2.4-12.219.1-3.5-2.9-15.5-16.8-13.4-29.9-14.0-3.132.511.03.2-62.3-3.0239.8-6.4-4.1-4.7117.6-3.160.5-0.6

Net Cash Provided By Used In Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-04-012016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-30
Value1718914063941941448217221619619417018713646226827219529218012198173150
Percentage of NetCashProvidedByUsedInOperatingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax12.86.811.85.68.016.312.76.914.216.916.016.312.313.810.130.225.525.420.525.618.012.410.618.016.4

Net Income Loss

us-gaap:NetIncomeLoss



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-302012-12-292012-09-29
Value106-199296381-6736807344-6971-1359-1359-1255194-334-10711256-94709613148-86111118111106105
Percentage of NetIncomeLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax7.9-1.47.70.85.46.8-6.03.16.65.73.6-5.66.0-102.1-102.1-92.613.1-24.2-7.98.43.7-9.06.610.111.54.8-8.811.912.312.212.013.7

us-gaap:StatementEquityComponents

us-gaap:RetainedEarnings



Period End2020-03-282019-09-282019-06-292019-03-302018-09-292018-06-302018-03-31
Value10692963-673680
Percentage of NetIncomeLoss100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax7.97.70.85.4-6.03.16.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:RetainedEarnings0.00.00.00.00.00.00.0

Profit Loss

Depreciation Depletion And Amortization

us-gaap:DepreciationDepletionAndAmortization



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-04-012016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-30
Value9310310294969910610810911111210918215217516712712712612112762474742
Percentage of DepreciationDepletionAndAmortization100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Increase Decrease In Other Operating Capital Net

us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-04-012016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-30
Value6-114-10-94-1-16228-162625-16-12412-37-1218-23-14
Percentage of IncreaseDecreaseInOtherOperatingCapitalNet100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Increase Decrease In Inventories

us-gaap:IncreaseDecreaseInInventories



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-04-012016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-30
Value-36-1104037-225543-12230141357-26-2-1229-63-9-22121336
Percentage of IncreaseDecreaseInInventories100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Net Cash Provided By Used In Investing Activities

us-gaap:NetCashProvidedByUsedInInvestingActivities



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-04-012016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-30
Value-74-106-651-68230-46-51-27-266-92287-452-425-448-2156-334-125-30-59-46-1563-35-285-296
Percentage of NetCashProvidedByUsedInInvestingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-5.6-8.0-54.7-5.919.6-3.9-4.5-2.3-0.25.1-0.8191.6-32.7-31.3-33.4-140.8-31.8-11.7-3.2-5.2-4.6-159.7-3.8-29.5-32.2

Payments To Acquire Property Plant And Equipment

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-04-012016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-30
Value33473533214523191333182234393857311631514237404024
Percentage of PaymentsToAcquirePropertyPlantAndEquipment100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Payments To Acquire Investments

Net Cash Provided By Used In Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-04-012016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-30
Value64-31-144219-41-34-175-199-162-383-172-3744914943-953-312570-61-46-471151-28585-5
Percentage of NetCashProvidedByUsedInFinancingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax4.8-2.4-12.219.1-3.5-2.9-15.5-16.8-13.4-29.9-14.0-3.132.511.03.2-62.3-3.0239.8-6.4-4.1-4.7117.6-3.160.5-0.6

Proceeds From Issuance Of Long Term Debt

Repayments Of Long Term Debt

us-gaap:RepaymentsOfLongTermDebt



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-04-012016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-30
Value00317146121212124443671413141414875138953935351965000
Percentage of RepaymentsOfLongTermDebt0.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.00.0
Percentage of LongTermDebtAndCapitalLeaseObligations0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Payments Of Dividends

us-gaap:PaymentsOfDividends



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-04-012016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-30
Value3028282825262526262222232018181817141414149888
Percentage of PaymentsOfDividends100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Payments Of Dividends

us-gaap:PaymentsOfDividends



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-04-012016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-30
Value3028282825262526262222232018181817141414149888
Percentage of PaymentsOfDividends100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Payments For Repurchase Of Common Stock

Repayments Of Long Term Debt

us-gaap:RepaymentsOfLongTermDebt



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-04-012016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-30
Value00317146121212124443671413141414875138953935351965000
Percentage of RepaymentsOfLongTermDebt0.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.00.0
Percentage of LongTermDebtAndCapitalLeaseObligations0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Debt Instrument Interest Rate Stated Percentage

us-gaap:DebtInstrument

us-gaap:DebtInstrumentInterestRateStatedPercentage

prgo:A4.375seniornotedueMarch152026



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-07-022016-03-072015-12-31
Value0.043750.043750.043750.043750.043750.043750.043750.043750.043750.043750.043750.043750.043750.043750.043750.04380.04375
Percentage of DebtInstrumentInterestRateStatedPercentage100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of LongTermDebtAndCapitalLeaseObligations0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Percentage of LongTermDebtAndCapitalLeaseObligations prgo:A4.375seniornotedueMarch1520260.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Effective Income Tax Rate Continuing Operations

us-gaap:EffectiveIncomeTaxRateContinuingOperations



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-302012-12-29
Value0.072-0.050000000000000020.0520.6660.2110.120000000000000050.1450.3450.269-0.11400000000000010.6550.0870.2530.2010.2820.0681.0940.1480.6410.0760.1710.114-0.0660.2330.2390.292-0.00200000000000000180.3010.271
Percentage of EffectiveIncomeTaxRateContinuingOperations100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price

Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period

Share Based Compensation

us-gaap:ShareBasedCompensation



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-04-012016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-30
Value1611121512114912151361310147778647544
Percentage of ShareBasedCompensation100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Deferred Tax Liabilities

Deferred Tax Assets Net

Unrecognized Tax Benefits

Deferred Tax Assets Valuation Allowance

Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions

Operating Lease Right Of Use Asset

us-gaap:OperatingLeaseRightOfUseAsset



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302019-01-012018-12-31
Value1241291311351461640
Percentage of OperatingLeaseRightOfUseAsset100.0100.0100.0100.0100.0100.00.0

us-gaap:BalanceSheetLocation

prgo:OperatingLeases



Period End2020-03-282019-12-312019-09-282019-06-292019-03-30
Value124129131135146
Percentage of OperatingLeaseRightOfUseAsset100.0100.0100.0100.0100.0

us-gaap:StatementBusinessSegments

prgo:ConsumerSelfCareAmericas



Period End2020-03-282019-12-312019-09-282019-06-292019-03-30
Value2122232230
Percentage of OperatingLeaseRightOfUseAsset17.317.217.516.820.5

prgo:ConsumerSelfCareInternational



Period End2020-03-282019-12-312019-09-282019-06-292019-03-30
Value3941404243
Percentage of OperatingLeaseRightOfUseAsset31.732.030.631.029.6

prgo:RXPharmaceuticals



Period End2020-03-282019-12-312019-09-282019-06-292019-03-30
Value3335363738
Percentage of OperatingLeaseRightOfUseAsset27.027.027.627.726.3

us-gaap:MaterialReconcilingItems



Period End2020-03-282019-12-312019-09-282019-06-292019-03-30
Value2930323334
Percentage of OperatingLeaseRightOfUseAsset24.023.724.324.523.6

Cash And Cash Equivalents Period Increase Decrease

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312016-12-31
Value5103543981055837551444526687678622
Percentage of CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Proceeds From Repayments Of Short Term Debt

prgo:CashFlowHedgeGainLossReclassifiedtoEarningsNet



Period End2020-03-282019-09-282019-06-292019-03-30
Value-100-1
Percentage of CashFlowHedgeGainLossReclassifiedtoEarningsNet100.0100.0100.0100.0

prgo:ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent



Period End2020-03-28
Value0.24
Percentage of ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent100.0

us-gaap:FinancialInstrument, us-gaap:MeasurementInputType, us-gaap:ValuationTechnique

prgo:ContingentConsiderationPaymentsSalesbasedMilestonesPercent

prgo:ContingentConsideration, us-gaap:MeasurementInputDiscountRate, us-gaap:ValuationTechniqueDiscountedCashFlow



Period End2020-03-28
Value0.525
Percentage of ContingentConsiderationPaymentsSalesbasedMilestonesPercent100.0

us-gaap:CounterpartyName

prgo:FairValueAssumptionVolatility

prgo:RoyaltyPharma



Period End2020-03-282019-09-282019-03-302018-09-29
Value0.350.30.30.3
Percentage of FairValueAssumptionVolatility100.0100.0100.0100.0

us-gaap:CounterpartyName

prgo:FairValueAssumptionsRateofReturn

prgo:RoyaltyPharma



Period End2020-03-282019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-01
Value0.07290.0799-0.00029999999999999470.0802-0.000199999999999991850.08070.000100000000000002860.08089.999999999998899e-050.08060.0805
Percentage of FairValueAssumptionsRateofReturn100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

prgo:FinanceLeaseCost



Period End2020-03-282019-09-282019-06-292019-03-30
Value1100
Percentage of FinanceLeaseCost100.0100.0100.0100.0

us-gaap:IncomeTaxAuthority, us-gaap:IncomeTaxAuthorityName, us-gaap:StatementScenario

prgo:ForeignStatutoryCorporateTaxRate

us-gaap:ForeignCountry, us-gaap:HerMajestysRevenueAndCustomsHMRC, us-gaap:ScenarioForecast



Period End2020-04-012017-04-01
Value0.180.19
Percentage of ForeignStatutoryCorporateTaxRate100.0100.0

prgo:IncreaseDecreaseInAccruedCustomerPrograms



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-04-012016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-30
Value-1334-298-6126-35161750-2-32-6927045-273318309452723
Percentage of IncreaseDecreaseInAccruedCustomerPrograms100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:LitigationCase

prgo:LossContingencyNumberofLawsuits

prgo:TalcumPowderLitigation



Period End2020-03-28
Value27.0
Percentage of LossContingencyNumberofLawsuits100.0

us-gaap:LitigationCase, us-gaap:SubsequentEventType

prgo:RanitidineLitigation, us-gaap:SubsequentEvent



Period End2020-04-29
Value6.0
Percentage of LossContingencyNumberofLawsuits0.0

prgo:OtherOperatingIncomeLoss



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-01
Value-11-80410-3-202136
Percentage of OtherOperatingIncomeLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

prgo:ProceedsfromContingentMilestonePayment



Period End2020-03-282019-03-302018-03-31
Value02500
Percentage of ProceedsfromContingentMilestonePayment0.0100.00.0

prgo:ProceedsfromRoyaltiesReceivedInvestingActivities



Period End2020-03-282019-03-30
Value11
Percentage of ProceedsfromRoyaltiesReceivedInvestingActivities100.0100.0

prgo:RestructuringAdditionalCharges



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-31
Value025125-21831
Percentage of RestructuringAdditionalCharges0.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-04-012016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-28
Value20617816017119139212143217195162167198184293314293229213261173176146
Percentage of AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation



Period End2020-03-282019-09-282019-06-292019-03-302018-09-292018-06-302018-03-31
Value5102111
Percentage of AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation100.0100.0100.0100.0100.0100.0100.0

us-gaap:StatementEquityComponents

us-gaap:CommonStock



Period End2020-03-282019-09-282019-06-292019-03-302018-09-292018-06-302018-03-31
Value5102111
Percentage of AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation100.0100.0100.0100.0100.0100.0100.0

us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition



Period End2020-03-282019-09-282019-06-292019-03-302018-09-292018-06-302018-03-31
Value151114143610
Percentage of AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition100.0100.0100.0100.0100.0100.0100.0

us-gaap:StatementEquityComponents

us-gaap:CommonStock



Period End2020-03-282019-09-282019-06-292019-03-302018-09-292018-06-302018-03-31
Value151114143610
Percentage of AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition100.0100.0100.0100.0100.0100.0100.0

us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition



Period End2020-03-282019-09-282019-06-292019-03-302018-09-292018-06-302018-03-31
Value0011022
Percentage of AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition100.0100.0100.0100.0100.0100.0100.0

us-gaap:StatementEquityComponents

us-gaap:CommonStock



Period End2020-03-282019-09-282019-06-292019-03-302018-09-292018-06-302018-03-31
Value0011022
Percentage of AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition100.0100.0100.0100.0100.0100.0100.0

us-gaap:AmortizationOfDebtDiscountPremium



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-04-01
Value000-1-1-1-2-1-2-4-6-6
Percentage of AmortizationOfDebtDiscountPremium100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AmortizationOfIntangibleAssets



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-302012-12-29
Value73777873757684858788888785162161158126147142107107106991074329292421
Percentage of AmortizationOfIntangibleAssets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:StatementBusinessSegments

prgo:ConsumerSelfCareAmericas



Period End2020-03-282019-09-282019-06-292019-03-302018-09-292018-06-302018-03-31
Value1312910151515
Percentage of AmortizationOfIntangibleAssets18.616.012.613.418.117.917.4

prgo:ConsumerSelfCareInternational



Period End2020-03-282019-09-282019-06-292019-03-302018-09-292018-06-302018-03-31
Value38434344484951
Percentage of AmortizationOfIntangibleAssets52.455.058.458.557.257.758.6

prgo:RXPharmaceuticals



Period End2020-03-282019-09-282019-06-292019-03-302018-09-292018-06-302018-03-312017-09-302017-07-012017-04-012016-10-01
Value2122212120202021222227
Percentage of AmortizationOfIntangibleAssets29.029.028.928.124.324.023.623.725.626.116.8

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount



Period End2020-03-282019-09-282019-06-292019-03-302018-09-292018-06-302018-03-312017-09-302017-07-012017-04-012016-10-012016-07-022016-04-022015-09-262015-06-272015-03-282014-12-272014-09-272014-03-292013-12-282013-09-282013-03-302012-12-29
Value11120101010100000000000
Percentage of AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount100.0100.0100.0100.00.0100.0100.0100.00.0100.00.0100.0100.0100.00.0100.0100.0100.00.0100.0100.0100.0100.0

us-gaap:AssetImpairmentCharges



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-28
Value0141102740221100727121679-19467215000
Percentage of AssetImpairmentCharges0.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.00.00.00.0

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-31
Value156-44-657217286106-82-1608
Percentage of CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:CommonStockDividendsPerShareDeclared



Period End2020-03-282019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-302012-12-29
Value0.230.210.210.190.190000000000000060.190.190.190.160000000000000030.160.160.160.1450.1450.1450.1250.1250.1250.1250.1050.1050.105000000000000040.1050.090.090.089999999999999970.090.09
Percentage of CommonStockDividendsPerShareDeclared100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DeferredIncomeTaxExpenseBenefit



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-04-012016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-30
Value6-54053-95-7-7-32-8-46-138-127-1468-46-18-20-26-219-148-4
Percentage of DeferredIncomeTaxExpenseBenefit100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DerivativeInstrumentRisk, us-gaap:HedgingDesignation, us-gaap:IncomeStatementLocation

us-gaap:DerivativeGainLossOnDerivativeNet

us-gaap:ForeignExchangeForward, us-gaap:Nondesignated, us-gaap:InterestExpense



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-28
Value100100000-2-100-10000-1-20-1000
Percentage of DerivativeGainLossOnDerivativeNet100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ForeignExchangeForward, us-gaap:Nondesignated, us-gaap:OtherNonoperatingIncomeExpense



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-28
Value102-14-4-81-21131610-5-80-1-60-85-255-41-1002
Percentage of DerivativeGainLossOnDerivativeNet611.8480.02940.0-307.1-2200.0-1000.01000.05900.0-388.9-683.3-561.1714.32225.020.0266.7-6900.0-112.5-8900.0-520.010228.013766.7120.0-300.0800.0-2200.0

us-gaap:HedgingDesignation

us-gaap:Nondesignated



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-03-302012-12-29
Value122-15-2-80-2122148-5-9-1-2-60-84-258-68-300-2-10
Percentage of DerivativeGainLossOnDerivativeNet711.8580.03040.0-207.1-2100.0-900.01100.06000.0-288.9-583.3-461.1814.32325.0120.0366.7-6800.0-12.5-8800.0-420.010328.022666.7220.0400.0-900.02100.00.00.0

us-gaap:DividendsCommonStockCash



Period End2020-03-282019-09-282019-06-292019-03-302018-09-292018-06-302018-03-31
Value30282825252626
Percentage of DividendsCommonStockCash100.0100.0100.0100.0100.0100.0100.0

us-gaap:StatementEquityComponents

us-gaap:CommonStock



Period End2020-03-282019-09-282019-06-292019-03-302018-09-292018-06-302018-03-31
Value30282825252626
Percentage of DividendsCommonStockCash100.0100.0100.0100.0100.0100.0100.0

us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents



Period End2020-03-282019-03-30
Value-53
Percentage of EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents100.0100.0

us-gaap:IncomeStatementLocation

us-gaap:EquitySecuritiesFvNiGainLoss

prgo:OtherExpenseIncomeNet



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-01
Value-230-1-620-6-4000
Percentage of EquitySecuritiesFvNiGainLoss100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.00.0

us-gaap:FairValueByAssetClass, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1

prgo:RoyaltyPharma2020ContingentMilestonePayments, us-gaap:FairValueInputsLevel3, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-282018-12-312018-09-292018-06-30
Value1573
Percentage of FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1100.0100.0100.0100.0

us-gaap:FairValueByAssetClass, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements

prgo:RoyaltyPharmaContingentMilestonePayments, us-gaap:FairValueInputsLevel3, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-31
Value00002500000
Percentage of FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements0.00.00.00.0100.00.00.00.00.0

us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings

us-gaap:FairValueInputsLevel3, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-30
Value-10-10-11-11
Percentage of FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements

us-gaap:FairValueInputsLevel3, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-30
Value00014000
Percentage of FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements0.0100.00.0100.0100.00.0100.00.0

us-gaap:FairValueOptionChangesInFairValueGainLoss1



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-27
Value132510122740-90-2-3817-11151115-377-910-204116173-69100-10558
Percentage of FairValueOptionChangesInFairValueGainLoss1100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FinanceLeaseInterestExpense



Period End2020-03-282019-09-282019-06-292019-03-30
Value200000.0200000.0100000.0100000.0
Percentage of FinanceLeaseInterestExpense100.0100.0100.0100.0

us-gaap:FinanceLeaseInterestPaymentOnLiability



Period End2020-03-282019-03-30
Value200000.0100000.0
Percentage of FinanceLeaseInterestPaymentOnLiability100.0100.0

us-gaap:FinanceLeasePrincipalPayments



Period End2020-03-282019-03-30
Value1000000.0700000.0
Percentage of FinanceLeasePrincipalPayments100.0100.0

us-gaap:FinanceLeaseRightOfUseAssetAmortization



Period End2020-03-282019-09-282019-06-292019-03-30
Value1000
Percentage of FinanceLeaseRightOfUseAssetAmortization100.0100.0100.0100.0

us-gaap:BusinessAcquisition, us-gaap:FiniteLivedIntangibleAssetsByMajorClass

us-gaap:FinitelivedIntangibleAssetsAcquired1

prgo:Dexsil, prgo:Brand



Period End2020-02-13
Value8
Percentage of FinitelivedIntangibleAssetsAcquired1100.0

prgo:Steripod, prgo:Brand



Period End2020-01-03
Value24
Percentage of FinitelivedIntangibleAssetsAcquired10.0

us-gaap:IncomeStatementLocation

us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet

us-gaap:CostOfSales



Period End2020-03-282019-09-282019-06-292019-03-30
Value000-1
Percentage of ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet100.0100.0100.0100.0

us-gaap:SalesRevenueNet



Period End2020-03-282019-09-282019-06-292019-03-30
Value-400000.0500000.0100000.0200000.0
Percentage of ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet66.7100.0-50.0-15.4

us-gaap:GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet



Period End2020-03-282019-09-282019-06-292019-03-30
Value00-1-1
Percentage of GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet100.0100.0100.0100.0

us-gaap:IncomeStatementLocation

us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness

us-gaap:CostOfSales



Period End2020-03-282019-09-282019-06-292019-03-30
Value00-1-1
Percentage of GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness100.0100.0100.0100.0

us-gaap:SalesRevenueNet



Period End2020-03-282019-09-282019-06-292019-03-30
Value0.0-200000.0100000.0-100000.0
Percentage of GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness0.0-66.7-9.19.1

us-gaap:GoodwillForeignCurrencyTranslationGainLoss



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-04-01
Value-2639-3911-13-14-6-7234295-34-26
Percentage of GoodwillForeignCurrencyTranslationGainLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:StatementBusinessSegments

prgo:ConsumerSelfCareAmericas



Period End2020-03-282019-12-312019-09-282019-06-292019-03-30
Value-52001
Percentage of GoodwillForeignCurrencyTranslationGainLoss21.35.6-0.88.0-8.8

prgo:ConsumerSelfCareInternational



Period End2020-03-282019-12-312019-09-282019-06-292019-03-30
Value-1736-428-17
Percentage of GoodwillForeignCurrencyTranslationGainLoss66.792.1107.375.2130.1

prgo:RXPharmaceuticals



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-31
Value-30212-20-5014
Percentage of GoodwillForeignCurrencyTranslationGainLoss12.02.3-6.516.8-21.319.4-9.16.9-0.94.9

us-gaap:GoodwillPurchaseAccountingAdjustments



Period End2020-03-282015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-03-29
Value0475-87000-130
Percentage of GoodwillPurchaseAccountingAdjustments0.0100.0100.00.00.00.0100.00.0

us-gaap:StatementBusinessSegments

prgo:ConsumerSelfCareAmericas



Period End2020-03-28
Value-10
Percentage of GoodwillPurchaseAccountingAdjustments0.0

prgo:ConsumerSelfCareInternational



Period End2020-03-28
Value10
Percentage of GoodwillPurchaseAccountingAdjustments0.0

prgo:RXPharmaceuticals



Period End2020-03-28
Value0.0
Percentage of GoodwillPurchaseAccountingAdjustments0.0

us-gaap:IncomeStatementLocation

us-gaap:IncomeLossFromEquityMethodInvestments

prgo:OtherExpenseIncomeNet



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-01
Value0001011000000
Percentage of IncomeLossFromEquityMethodInvestments100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:IncreaseDecreaseInAccountsPayable



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-04-012016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-30
Value53-16-7-3475-15-443157-33020-5-19416918-14-322718-3-67230
Percentage of IncreaseDecreaseInAccountsPayable100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:IncreaseDecreaseInAccountsReceivable



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-04-012016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-30
Value67128-436480-4426-23513-50-23-39-46116-3961-571362419453122
Percentage of IncreaseDecreaseInAccountsReceivable100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-04-012016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-30
Value3-8-29-26-10128-39-27655244199-451536-5117141029-8534-218
Percentage of IncreaseDecreaseInAccruedIncomeTaxesPayable100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:IncreaseDecreaseInAccruedLiabilities



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-04-012016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-30
Value111-5-15-3100-6-24-29302-31461-12-2510146-1921-117
Percentage of IncreaseDecreaseInAccruedLiabilities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-04-012016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-30
Value-18612-3-1967-9-3891-10-37-15-22-2-18-34-15-5422-89-1
Percentage of IncreaseDecreaseInEmployeeRelatedLiabilities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:IncreaseDecreaseInOperatingCapital



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-04-012016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-30
Value34882010796-154686145-21-33-2727-3157-14725-4318-31-65448155
Percentage of IncreaseDecreaseInOperatingCapital100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:IncreaseDecreaseInPrepaidExpense



Period End2020-03-282019-03-30
Value333
Percentage of IncreaseDecreaseInPrepaidExpense100.0100.0

us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-302012-12-29
Value10000000000000000000000000000
Percentage of IncrementalCommonSharesAttributableToShareBasedPaymentArrangements100.0100.0100.0100.0100.00.00.0100.0100.00.0100.00.0100.00.0100.00.0100.0100.0100.00.0100.0100.00.0100.00.0100.00.0100.0100.0

us-gaap:InterestIncomeExpenseNet



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-302012-12-29
Value-30-31-30-31-28-32-31-32-31-35-34-45-53-54-57-51-46-43-45-43-30-25-26-26-29-21-18-16-15
Percentage of InterestIncomeExpenseNet100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent



Period End2020-03-28
Value-102
Percentage of OciBeforeReclassificationsNetOfTaxAttributableToParent100.0

us-gaap:StatementEquityComponents

us-gaap:AccumulatedDefinedBenefitPlansAdjustment



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-31
Value-15-1001-100
Percentage of OciBeforeReclassificationsNetOfTaxAttributableToParent1.90.00.00.00.00.00.00.00.0

us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedges



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-31
Value-8-5321-1-30-30
Percentage of OciBeforeReclassificationsNetOfTaxAttributableToParent7.80.00.00.00.00.00.00.00.0

us-gaap:AccumulatedTranslationAdjustment



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-31
Value-9291-7427-16-53-9-16573
Percentage of OciBeforeReclassificationsNetOfTaxAttributableToParent90.30.00.00.00.00.00.00.00.0

us-gaap:OperatingLeaseCost



Period End2020-03-282019-09-282019-06-292019-03-30
Value11111112
Percentage of OperatingLeaseCost100.0100.0100.0100.0

us-gaap:OperatingLeasePayments



Period End2020-03-282019-03-30
Value1011
Percentage of OperatingLeasePayments100.0100.0

us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-01
Value100004100-1210
Percentage of OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.00.0

us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent



Period End2020-03-282019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-302012-12-29
Value-9312100-3010613-1-52040-3-20-1-1-9-215
Percentage of OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0

us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-01
Value-9291-7427-16-53-9-165733869154
Percentage of OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax



Period End2020-03-282019-12-312019-09-282019-03-30
Value7-32-1
Percentage of OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax100.0100.0100.0100.0

us-gaap:DerivativeInstrumentRisk

us-gaap:ForeignExchangeForward



Period End2020-03-282019-12-312019-09-282019-06-292019-03-30
Value7-321-1
Percentage of OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax100.0100.0100.00.0100.0

us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012014-06-282014-03-292013-12-282013-06-292013-03-302012-12-29
Value-10382-4230-15-58-11-16972616015691510-10634
Percentage of OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:StatementEquityComponents

us-gaap:AccumulatedDefinedBenefitPlansAdjustment



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-31
Value-10000-4-100
Percentage of OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent1.8-1.01.20.03.27.38.50.1-0.3

us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedges



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-31
Value-9-7312100-30
Percentage of OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent9.1-9.4-73.78.9-10.91.27.62.1-0.8

us-gaap:AccumulatedOtherComprehensiveIncome



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-31
Value-10382-4230-15-58-11-16972
Percentage of OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AccumulatedTranslationAdjustment



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-31
Value-9291-7427-16-53-9-16573
Percentage of OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent89.1110.4172.591.1107.791.583.997.8101.1

us-gaap:OtherOperatingActivitiesCashFlowStatement



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-04-012016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-29
Value-14-11121313-170-71224-6-1114390805-1
Percentage of OtherOperatingActivitiesCashFlowStatement100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:PaymentsForProceedsFromOtherInvestingActivities



Period End2020-03-282019-12-312019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-04-012016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-29
Value-1-200000920105-100-1150
Percentage of PaymentsForProceedsFromOtherInvestingActivities100.0100.00.00.00.00.00.0100.0100.0100.0100.00.0100.0100.00.0100.0100.0100.00.0

us-gaap:PaymentsForRestructuring



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-28
Value347993131012172378618411021361741
Percentage of PaymentsForRestructuring100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:BusinessAcquisition

us-gaap:PaymentsToAcquireBusinessesGross

prgo:Steripod



Period End2020-01-03
Value26
Percentage of PaymentsToAcquireBusinessesGross100.0

us-gaap:BusinessAcquisition, us-gaap:StatementBusinessSegments, us-gaap:SubsequentEventType

prgo:OralCareAssetsofHighRidgeBrands, prgo:ConsumerSelfCareAmericas, us-gaap:SubsequentEvent



Period End2020-04-01
Value113
Percentage of PaymentsToAcquireBusinessesGross0.0

us-gaap:BusinessAcquisition, us-gaap:SubsequentEventType

prgo:OralCareAssetsofHighRidgeBrands, us-gaap:SubsequentEvent



Period End2020-02-20
Value113
Percentage of PaymentsToAcquireBusinessesGross0.0

prgo:Steripod, us-gaap:SubsequentEvent



Period End2020-01-03
Value24
Percentage of PaymentsToAcquireBusinessesGross95.0

us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired



Period End2020-03-282019-12-312019-09-282019-03-302017-12-312017-09-302017-04-012016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-06-292013-03-30
Value11-1749000041638640520944830770244280
Percentage of PaymentsToAcquireBusinessesNetOfCashAcquired100.0100.0100.00.0100.00.00.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0

us-gaap:PaymentsToAcquireOtherProductiveAssets



Period End2020-03-282019-03-30
Value320
Percentage of PaymentsToAcquireOtherProductiveAssets100.00.0

us-gaap:ProceedsFromPaymentsForOtherFinancingActivities



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-04-012016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-29
Value-6-2-1-2-30-2-1-50-20-3-124-15-1-60-40
Percentage of ProceedsFromPaymentsForOtherFinancingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0

us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-04-012016-04-022015-12-312015-09-262015-03-282014-09-27
Value1020-396397040-2-6600-704683793-2
Percentage of ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0

us-gaap:ProductionAndDistributionCosts



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-28
Value2425232323232223242221212121222123242314141414131413
Percentage of ProductionAndDistributionCosts100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent



Period End2020-03-28
Value1
Percentage of ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent100.0

us-gaap:StatementEquityComponents

us-gaap:AccumulatedDefinedBenefitPlansAdjustment



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-31
Value060005000
Percentage of ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent0.00.00.00.00.00.00.00.00.0

us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedges



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-31
Value120-1-2-3000
Percentage of ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent100.00.00.00.00.00.00.00.00.0

us-gaap:RestructuringCharges



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-292013-03-302012-12-29
Value005129-2183163123865524201211019142200
Percentage of RestructuringCharges0.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.0

us-gaap:RestructuringReserveSettledWithoutCash2



Period End2020-03-282019-09-282019-06-292019-03-302018-09-292018-06-302018-03-312017-09-302017-07-012017-04-012016-10-012016-07-022016-04-022015-09-262015-06-27
Value000000000000500
Percentage of RestructuringReserveSettledWithoutCash2100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.00.0100.0100.00.0

us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability



Period End2020-03-282019-03-30
Value10
Percentage of RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability100.00.0

us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability



Period End2020-03-282019-03-30
Value54
Percentage of RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability100.0100.0

us-gaap:StatementEquityComponents

us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures

us-gaap:CommonStock



Period End2020-03-282019-09-282019-03-302018-09-292018-06-302018-03-31
Value300000.0100000.0200000.0-100000.0100000.0200000.0
Percentage of StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures100.0100.0100.0100.0100.0100.0

prgo:AccruedCustomerPrograms



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-06-29
Value380394358385379442416451438419368370348380325354331398367368282310274256219210131
Percentage of AccruedCustomerPrograms100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FairValueByAssetClass, us-gaap:StatementScenario

prgo:AssetAdjustedFairValueifSalesThresholdMet

prgo:RoyaltyPharmaContingentMilestonePayments, us-gaap:ScenarioForecast



Period End2020-12-31
Value400
Percentage of AssetAdjustedFairValueifSalesThresholdMet100.0

us-gaap:StatementScenario

srt:ScenarioForecast



Period End2020-12-31
Value400
Percentage of AssetAdjustedFairValueifSalesThresholdMet100.0

us-gaap:ScenarioForecast



Period End2020-12-31
Value400
Percentage of AssetAdjustedFairValueifSalesThresholdMet100.0

us-gaap:StatementScenario, us-gaap:FairValueByAssetClass

srt:ScenarioForecast, prgo:RoyaltyPharmaContingentMilestonePayments



Period End2020-12-31
Value400
Percentage of AssetAdjustedFairValueifSalesThresholdMet100.0

us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

prgo:FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure

us-gaap:FairValueInputsLevel2, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-07-022016-04-022015-12-312015-06-272014-06-28
Value13141414131314141516161817151617171719
Percentage of FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

prgo:GoodwillAndIndefiniteLivedIntangibles



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-06-29
Value414641854269396739994029404242274300426542554253417841635282662770337281735572353467348135033543327632551174
Percentage of GoodwillAndIndefiniteLivedIntangibles100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

prgo:LeaseLiabilities



Period End2020-03-282019-12-312019-09-282019-06-292019-03-30
Value152158159154157
Percentage of LeaseLiabilities100.0100.0100.0100.0100.0

us-gaap:LitigationCase

prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals

prgo:BurlingtonLoanManagementDACv.PerrigoCo.plcetal.



Period End2020-02-12
Value6.0
Percentage of LossContingencyNumberOfGenericPrescriptionPharmaceuticals100.0

prgo:PrincipalFundsInc.etal.v.PerrigoCompanyplcetal.



Period End2020-03-05
Value6.0
Percentage of LossContingencyNumberOfGenericPrescriptionPharmaceuticals0.0

prgo:UniversitiesSuperannuationSchemeLimitedv.PerrigoCo.plcetal.



Period End2020-03-02
Value6.0
Percentage of LossContingencyNumberOfGenericPrescriptionPharmaceuticals0.0

us-gaap:LitigationCase, us-gaap:SubsequentEventType

prgo:BlackRockGlobalAllocationFundetal.v.PerrigoCo.plcetal., us-gaap:SubsequentEvent



Period End2020-04-21
Value6.0
Percentage of LossContingencyNumberOfGenericPrescriptionPharmaceuticals0.0

prgo:BurlingtonLoanManagementDACv.PerrigoCo.plcetal., us-gaap:SubsequentEvent



Period End2020-02-12
Value6.0
Percentage of LossContingencyNumberOfGenericPrescriptionPharmaceuticals100.0

prgo:KuwaitInvestmentAuthorityetal.v.PerrigoCompanyplcetal., us-gaap:SubsequentEvent



Period End2020-03-31
Value6.0
Percentage of LossContingencyNumberOfGenericPrescriptionPharmaceuticals0.0

us-gaap:LitigationCase

prgo:LossContingencyNumberOfOptOutCases

prgo:BurlingtonLoanManagementDACv.PerrigoCo.plcetal.



Period End2020-02-12
Value15.0
Percentage of LossContingencyNumberOfOptOutCases100.0

prgo:PrincipalFundsInc.etal.v.PerrigoCompanyplcetal.



Period End2020-03-05
Value17.0
Percentage of LossContingencyNumberOfOptOutCases0.0

prgo:UniversitiesSuperannuationSchemeLimitedv.PerrigoCo.plcetal.



Period End2020-03-02
Value16.0
Percentage of LossContingencyNumberOfOptOutCases0.0

us-gaap:LitigationCase, us-gaap:SubsequentEventType

prgo:BlackRockGlobalAllocationFundetal.v.PerrigoCo.plcetal., us-gaap:SubsequentEvent



Period End2020-04-21
Value19.0
Percentage of LossContingencyNumberOfOptOutCases0.0

prgo:BurlingtonLoanManagementDACv.PerrigoCo.plcetal., us-gaap:SubsequentEvent



Period End2020-02-12
Value14.0
Percentage of LossContingencyNumberOfOptOutCases93.3

prgo:KuwaitInvestmentAuthorityetal.v.PerrigoCompanyplcetal., us-gaap:SubsequentEvent



Period End2020-03-31
Value18.0
Percentage of LossContingencyNumberOfOptOutCases0.0

us-gaap:LitigationCase

prgo:LossContingencyNumberofCodefendants

prgo:PricefixingLawsuitHarrisCountyofTexas



Period End2020-03-01
Value29.0
Percentage of LossContingencyNumberofCodefendants100.0

prgo:PrincipalFundsInc.etal.v.PerrigoCompanyplcetal.



Period End2020-03-05
Value2.0
Percentage of LossContingencyNumberofCodefendants0.0

us-gaap:LitigationCase, us-gaap:SubsequentEventType

prgo:KuwaitInvestmentAuthorityetal.v.PerrigoCompanyplcetal., us-gaap:SubsequentEvent



Period End2020-03-31
Value2.0
Percentage of LossContingencyNumberofCodefendants0.0

us-gaap:LitigationCase

prgo:NumberofCaseswithSimilarFactualAllegations

prgo:BurlingtonLoanManagementDACv.PerrigoCo.plcetal.



Period End2020-02-12
Value6.0
Percentage of NumberofCaseswithSimilarFactualAllegations100.0

prgo:UniversitiesSuperannuationSchemeLimitedv.PerrigoCo.plcetal.



Period End2020-03-02
Value6.0
Percentage of NumberofCaseswithSimilarFactualAllegations0.0

us-gaap:LitigationCase, us-gaap:SubsequentEventType

prgo:BurlingtonLoanManagementDACv.PerrigoCo.plcetal., us-gaap:SubsequentEvent



Period End2020-02-12
Value6.0
Percentage of NumberofCaseswithSimilarFactualAllegations100.0

us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

prgo:PotentialContingentMilestonePayments

us-gaap:FairValueInputsLevel3, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302017-12-312016-12-312015-12-31
Value969591898332320012513400
Percentage of PotentialContingentMilestonePayments100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.0

us-gaap:StatementScenario

us-gaap:ScenarioForecast



Period End2020-12-312018-12-31
Value5479
Percentage of PotentialContingentMilestonePayments0.024.7

prgo:RightofUseAsset



Period End2020-03-282019-12-31
Value151157
Percentage of RightofUseAsset100.0100.0

us-gaap:AccruedLiabilitiesCurrent



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-06-29
Value24822921326223220119419220523027424028126325829530730830824623023017917915214095
Percentage of AccruedLiabilitiesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AllowanceForDoubtfulAccountsReceivable



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282013-06-29
Value7666666666656644332213222
Percentage of AllowanceForDoubtfulAccountsReceivable100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

us-gaap:AssetsFairValueDisclosure

us-gaap:FairValueInputsLevel1, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302017-12-312015-12-312015-06-272014-06-28
Value3622397817141220
Percentage of AssetsFairValueDisclosure100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FairValueInputsLevel2, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-07-022016-04-022015-12-312015-06-272014-06-28
Value36455218161617162022293423192027222922
Percentage of AssetsFairValueDisclosure975.7684.82030.8642.9448.6178.7250.0208.60.0132.90.00.00.00.00.00.0147.7233.9108.2

us-gaap:FairValueInputsLevel3, us-gaap:FairValueMeasurementsNonrecurring



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-06-27
Value0103611007575111193724192418582944284318510
Percentage of AssetsFairValueDisclosure0.015703.0446.20.00.0798.91072.967.60.00.00.00.00.00.00.012424.80.0

us-gaap:FairValueInputsLevel3, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302017-12-312017-09-302017-07-012017-04-012016-12-312015-12-312015-06-272014-06-28
Value96959189833232001251341431451842350000
Percentage of AssetsFairValueDisclosure2618.91443.93526.93182.12259.53438.32862.91549.4791.20.00.00.00.00.00.00.0

us-gaap:AssetsNoncurrent



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282013-06-29
Value835485448571799381108081817484478738880988708970886611064148401650016751166491682216537110521109611147113293114
Percentage of AssetsNoncurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

us-gaap:BusinessCombinationContingentConsiderationLiability

us-gaap:FairValueInputsLevel3, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312016-12-312015-12-312014-06-28
Value13111312121516161822691717
Percentage of BusinessCombinationContingentConsiderationLiability100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ContractWithCustomerAssetGrossCurrent



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312018-01-01
Value28262516182528192620
Percentage of ContractWithCustomerAssetGrossCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DebtInstrumentFeeAmount



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282013-06-29
Value13141414151617181917192032333435373639404243262713
Percentage of DebtInstrumentFeeAmount100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272014-06-28
Value-6-7-7-8-9-12-14-16-20-21-24-29-27-33-43-49-58-73-80-876
Percentage of DebtInstrumentUnamortizedDiscountPremiumNet100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DebtLongtermAndShorttermCombinedAmount



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-06-29
Value347033693364348332173242326532833338334136923674579457975903641065215989537553114726480131923234326733001974
Percentage of DebtLongtermAndShorttermCombinedAmount100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DeferredIncomeTaxAssetsNet



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312015-12-31
Value6526210119102231767271
Percentage of DeferredIncomeTaxAssetsNet100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DeferredIncomeTaxLiabilitiesNet



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312015-12-31
Value2862803142802822822942903323213573683493891372
Percentage of DeferredIncomeTaxLiabilitiesNet100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:BalanceSheetLocation, us-gaap:DerivativeInstrumentRisk, us-gaap:HedgingDesignation

us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral

us-gaap:PrepaidExpensesAndOtherCurrentAssets, us-gaap:CurrencySwap, us-gaap:DesignatedAsHedgingInstrument



Period End2020-03-282019-12-312019-09-282018-12-31
Value1126300
Percentage of DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral100.0100.0100.00.0

us-gaap:PrepaidExpensesAndOtherCurrentAssets, us-gaap:ForeignExchangeForward, us-gaap:DesignatedAsHedgingInstrument



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302017-12-31
Value512102124
Percentage of DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral46.53.88.00.00.00.00.00.00.0

us-gaap:PrepaidExpensesAndOtherCurrentAssets, us-gaap:ForeignExchangeForward, us-gaap:Nondesignated



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302017-12-31
Value536321202
Percentage of DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral50.912.519.90.00.00.00.00.00.0

us-gaap:HedgingDesignation

us-gaap:DesignatedAsHedgingInstrument



Period End2020-03-282019-12-312019-09-282018-12-312015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-06-29
Value16273223233102357
Percentage of DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral146.5103.8108.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:BalanceSheetLocation, us-gaap:DerivativeInstrumentRisk, us-gaap:HedgingDesignation

us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral

us-gaap:OtherLiabilities, us-gaap:ForeignExchangeForward, us-gaap:DesignatedAsHedgingInstrument



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-06-29
Value1043246552122130112222440000
Percentage of DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0

us-gaap:OtherLiabilities, us-gaap:ForeignExchangeForward, us-gaap:Nondesignated



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-06-29
Value2311121412010201113264020100
Percentage of DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral25.778.736.138.538.143.826.982.072.7171.426.937.931.666.7166.7180.0100.095.0136.0130.0305.0843.858.514.30.0200.0100.0

us-gaap:Currency, us-gaap:DerivativeInstrumentRisk

us-gaap:DerivativeNotionalAmount

currency:CAD, us-gaap:ForeignExchangeForward



Period End2020-03-282019-12-312019-09-282018-12-31
Value27414831
Percentage of DerivativeNotionalAmount100.0100.0100.0100.0

currency:CHF, us-gaap:ForeignExchangeForward



Period End2020-03-282019-12-312018-12-31
Value442
Percentage of DerivativeNotionalAmount16.19.98.2

currency:CNY, us-gaap:ForeignExchangeForward



Period End2020-03-282019-12-312019-09-282018-12-31
Value1420180
Percentage of DerivativeNotionalAmount53.350.638.60.0

currency:DKK, us-gaap:ForeignExchangeForward



Period End2020-03-282019-12-312019-09-282018-12-31
Value52515156
Percentage of DerivativeNotionalAmount191.2125.2106.8178.2

currency:EUR, us-gaap:ForeignExchangeForward



Period End2020-03-282019-12-312019-09-282018-12-31
Value150157550134
Percentage of DerivativeNotionalAmount549.3381.61137.2423.3

currency:GBP, us-gaap:ForeignExchangeForward



Period End2020-03-282019-12-312019-09-282018-12-31
Value79867790
Percentage of DerivativeNotionalAmount290.9210.4161.0284.5

currency:ILS, us-gaap:ForeignExchangeForward



Period End2020-03-282019-12-312019-09-282018-12-31
Value288712413232
Percentage of DerivativeNotionalAmount1052.21725.7855.0733.8

currency:MXN, us-gaap:ForeignExchangeForward



Period End2020-03-282019-12-312019-09-282018-12-31
Value129425
Percentage of DerivativeNotionalAmount45.623.58.781.7

currency:NOK, us-gaap:ForeignExchangeForward



Period End2020-03-282019-12-312019-09-282018-12-31
Value0696
Percentage of DerivativeNotionalAmount1.116.019.419.6

currency:PLN, us-gaap:ForeignExchangeForward



Period End2020-03-282019-12-312019-09-282018-12-31
Value7211518
Percentage of DerivativeNotionalAmount28.552.132.957.4

currency:RON, us-gaap:ForeignExchangeForward



Period End2020-03-282019-12-312019-09-282018-12-31
Value0214
Percentage of DerivativeNotionalAmount1.55.62.713.9

currency:SEK, us-gaap:ForeignExchangeForward



Period End2020-03-282019-12-312019-09-282018-12-31
Value14424338
Percentage of DerivativeNotionalAmount51.1101.790.3122.1

currency:USD, us-gaap:ForeignExchangeForward



Period End2020-03-282019-12-312019-09-282018-12-31
Value55928039
Percentage of DerivativeNotionalAmount204.0223.7166.7124.0

currency:XXX, us-gaap:ForeignExchangeForward



Period End2020-03-282019-12-312019-09-282018-12-31
Value4748
Percentage of DerivativeNotionalAmount17.218.28.327.4

us-gaap:DerivativeInstrumentRisk

us-gaap:ForeignExchangeForward



Period End2020-03-282019-12-312019-09-282018-12-31
Value71212571320686
Percentage of DerivativeNotionalAmount2601.83044.12727.52165.9

us-gaap:EmployeeRelatedLiabilitiesCurrent



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-06-29
Value135156147126117132129103113148133131146115106989212511213385857711210315882
Percentage of EmployeeRelatedLiabilitiesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:BalanceSheetLocation

us-gaap:EquityMethodInvestments

us-gaap:OtherNoncurrentAssets



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282013-06-29
Value1817171615151413444444428454848525255574
Percentage of EquityMethodInvestments100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:BalanceSheetLocation

us-gaap:EquitySecuritiesFvNi

us-gaap:OtherNoncurrentAssets



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-30
Value22223444
Percentage of EquitySecuritiesFvNi100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:PrepaidExpensesAndOtherCurrentAssets



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-30
Value36223978
Percentage of EquitySecuritiesFvNi160.9287.0113.0100.0100.0213.6145.8176.1

us-gaap:FairValueByAssetClass, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue

prgo:RoyaltyPharma2020ContingentMilestonePayments, us-gaap:FairValueInputsLevel3, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-28
Value96
Percentage of FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue100.0

prgo:RoyaltyPharmaContingentMilestonePayments, us-gaap:FairValueInputsLevel3, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-31
Value96959189833232001251241341431451840
Percentage of FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue100.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue

us-gaap:FairValueInputsLevel3, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-31
Value13111312121516161822
Percentage of FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FinanceLeaseLiability



Period End2020-03-282019-12-312019-09-282019-06-292019-03-30
Value252424136
Percentage of FinanceLeaseLiability100.0100.0100.0100.0100.0

us-gaap:StatementBusinessSegments

prgo:ConsumerSelfCareAmericas



Period End2020-03-282019-12-312019-09-282019-06-292019-03-30
Value16161681
Percentage of FinanceLeaseLiability65.667.870.161.321.2

prgo:ConsumerSelfCareInternational



Period End2020-03-282019-12-312019-09-282019-06-292019-03-30
Value22233
Percentage of FinanceLeaseLiability10.811.812.023.450.0

prgo:RXPharmaceuticals



Period End2020-03-282019-12-312019-09-282019-06-292019-03-30
Value700000.0800000.0700000.0300000.0100000.0
Percentage of FinanceLeaseLiability2.83.32.92.21.5

us-gaap:MaterialReconcilingItems



Period End2020-03-282019-12-312019-09-282019-06-292019-03-30
Value54311
Percentage of FinanceLeaseLiability20.817.114.913.127.3

us-gaap:BalanceSheetLocation

us-gaap:FinanceLeaseLiabilityCurrent

prgo:CurrentIndebtedness



Period End2020-03-282019-12-31
Value53
Percentage of FinanceLeaseLiabilityCurrent100.0100.0

us-gaap:BalanceSheetLocation

us-gaap:FinanceLeaseLiabilityNoncurrent

prgo:LongtermDebtLessCurrentPortion



Period End2020-03-282019-12-31
Value1921
Percentage of FinanceLeaseLiabilityNoncurrent100.0100.0

us-gaap:FinanceLeaseRightOfUseAsset



Period End2020-03-282019-12-312019-09-282019-06-292019-03-30
Value272727179
Percentage of FinanceLeaseRightOfUseAsset100.0100.0100.0100.0100.0

us-gaap:BalanceSheetLocation

us-gaap:OtherNoncurrentAssets



Period End2020-03-282019-12-312019-09-282019-06-292019-03-30
Value272727179
Percentage of FinanceLeaseRightOfUseAsset100.0100.0100.0100.0100.0

us-gaap:StatementBusinessSegments

prgo:ConsumerSelfCareAmericas



Period End2020-03-282019-12-312019-09-282019-06-292019-03-30
Value16161781
Percentage of FinanceLeaseRightOfUseAsset58.860.963.252.019.2

prgo:ConsumerSelfCareInternational



Period End2020-03-282019-12-312019-09-282019-06-292019-03-30
Value55566
Percentage of FinanceLeaseRightOfUseAsset20.421.021.035.761.6

prgo:RXPharmaceuticals



Period End2020-03-282019-12-312019-09-282019-06-292019-03-30
Value700000.0800000.0700000.0300000.0100000.0
Percentage of FinanceLeaseRightOfUseAsset2.52.92.61.81.0

us-gaap:MaterialReconcilingItems



Period End2020-03-282019-12-312019-09-282019-06-292019-03-30
Value54311
Percentage of FinanceLeaseRightOfUseAsset18.315.213.210.518.2

us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-06-29
Value18191763168716521588152014581521147313711274120011181020179716331485132111951055905801703607502393316
Percentage of FiniteLivedIntangibleAssetsAccumulatedAmortization100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FiniteLivedIntangibleAssetsByMajorClass

us-gaap:CustomerRelationships



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-06-29
Value69467162861358756654151350046042438433930728825622919318114611110610197918472
Percentage of FiniteLivedIntangibleAssetsAccumulatedAmortization38.238.137.237.237.037.337.133.734.033.633.332.130.430.116.115.715.414.615.213.912.313.314.516.118.121.522.9

us-gaap:DevelopedTechnologyRights



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-06-29
Value770755717706686654634647629598568566562526529492462426402383352330316302277255204
Percentage of FiniteLivedIntangibleAssetsAccumulatedAmortization42.342.842.542.743.243.143.542.542.743.744.647.250.351.529.430.131.132.233.736.338.941.345.049.855.364.864.7

us-gaap:LicensingAgreements



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-06-272014-06-28
Value82811071051019995188180169157145132120914831749667502192
Percentage of FiniteLivedIntangibleAssetsAccumulatedAmortization4.54.66.36.46.46.56.612.412.212.412.412.111.911.850.850.950.550.547.631.6

us-gaap:NoncompeteAgreements



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-06-29
Value66571111131312121212111111101312121161099876
Percentage of FiniteLivedIntangibleAssetsAccumulatedAmortization0.30.30.30.50.70.80.90.90.90.91.01.01.01.10.60.70.91.01.01.10.71.31.41.51.71.91.9

us-gaap:TrademarksAndTradeNames



Period End2020-03-282019-12-312019-06-292019-03-302018-12-312017-12-31
Value265250219201188129
Percentage of FiniteLivedIntangibleAssetsAccumulatedAmortization14.614.213.312.712.49.4

us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure

us-gaap:FairValueInputsLevel3, us-gaap:FairValueMeasurementsNonrecurring



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012015-12-312015-06-27
Value023110022220011111107586600
Percentage of FiniteLivedIntangibleAssetsFairValueDisclosure0.0100.0100.00.00.0100.0100.00.00.0100.0100.0100.00.0100.0100.00.00.0

us-gaap:FiniteLivedIntangibleAssetsGross



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-06-29
Value469646854587432743464379441745874732466146214573445944171013810313100049512948591607433743873757394768376171473
Percentage of FiniteLivedIntangibleAssetsGross100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FiniteLivedIntangibleAssetsByMajorClass

us-gaap:CustomerRelationships



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-06-29
Value17921805176215581562158616011608167516421623158415051489156415451573152018881749364366369372370360358
Percentage of FiniteLivedIntangibleAssetsGross38.238.538.436.035.936.236.335.135.435.235.134.633.833.715.415.015.716.019.919.14.94.95.05.04.84.724.3

us-gaap:DevelopedTechnologyRights



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-09-152015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-06-29
Value139313921373132113331318132413491362135813551385142814181805178417951383101501025977902916931925923896
Percentage of FiniteLivedIntangibleAssetsGross29.729.729.930.530.730.130.029.428.829.129.330.332.032.117.817.317.914.510.70.011.213.112.112.412.612.012.160.9

us-gaap:LicensingAgreements



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-06-272014-06-28
Value133126183173180178180310312311310309307305612260566054605360296027
Percentage of FiniteLivedIntangibleAssetsGross2.82.74.04.04.24.14.16.86.66.76.76.86.96.960.458.760.563.665.881.5

us-gaap:NoncompeteAgreements



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-06-29
Value66681212141414141414141414141715151414141515151313
Percentage of FiniteLivedIntangibleAssetsGross0.10.10.10.20.30.30.30.30.30.30.30.30.30.30.10.10.20.20.20.20.20.20.20.20.20.20.9

us-gaap:TrademarksAndTradeNames



Period End2020-03-282019-12-312019-06-292019-03-302018-12-312017-12-31
Value137013531266125712821335
Percentage of FiniteLivedIntangibleAssetsGross29.228.929.328.929.328.6

us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue

us-gaap:FairValueInputsLevel2, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292017-12-31
Value114843336
Percentage of ForeignCurrencyCashFlowHedgeAssetAtFairValue100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue

us-gaap:FairValueInputsLevel2, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-06-272014-06-28
Value138435969333425023340
Percentage of ForeignCurrencyCashFlowHedgeLiabilityAtFairValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

us-gaap:ForeignCurrencyContractAssetFairValueDisclosure

us-gaap:FairValueInputsLevel2, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-282019-12-312019-09-282018-12-312018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-06-272014-06-28
Value11263002561316635494123
Percentage of ForeignCurrencyContractAssetFairValueDisclosure100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

us-gaap:GoodwillFairValueDisclosure

us-gaap:FairValueInputsLevel3, us-gaap:FairValueMeasurementsNonrecurring



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-06-27
Value01013000420000114811051792176100
Percentage of GoodwillFairValueDisclosure0.0100.00.00.00.0100.00.00.00.00.0100.0100.0100.0100.00.00.0

us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282013-06-29
Value56684632324947899190103102101114792135517511916236822636364666984
Percentage of IndefiniteLivedIntangibleAssetsExcludingGoodwill100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:IndefiniteLivedIntangibleAssetsByMajorClass

prgo:TrademarksTradeNamesandBrands



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-31
Value17181718181818515252
Percentage of IndefiniteLivedIntangibleAssetsExcludingGoodwill31.327.337.455.456.436.738.757.757.857.7

us-gaap:InProcessResearchAndDevelopment



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022016-03-012016-01-222015-12-312015-12-152015-09-262015-09-152015-08-282015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-06-29
Value38502914143129373838515151646766692904805005777109927
Percentage of IndefiniteLivedIntangibleAssetsExcludingGoodwill68.772.762.644.643.663.361.342.342.242.349.749.950.155.98.64.94.00.00.02.50.00.20.00.00.311.011.311.614.60.00.032.8

us-gaap:InventoryRawMaterials



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272014-06-28
Value256250259246239235231222215199203213199198202222218209220211177
Percentage of InventoryRawMaterials100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:InventoryWorkInProcess



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272014-06-28
Value188186195192199197180175161152146136151165171148144151163158146
Percentage of InventoryWorkInProcess100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

us-gaap:InvestmentsFairValueDisclosure

us-gaap:FairValueInputsLevel1, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-06-272014-06-28
Value3622397813176132238534038141220
Percentage of InvestmentsFairValueDisclosure100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

us-gaap:LiabilitiesFairValueDisclosure

us-gaap:FairValueInputsLevel2, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302017-12-312016-12-312016-10-012016-07-022016-04-022015-12-312015-06-272014-06-28
Value13843596935023449
Percentage of LiabilitiesFairValueDisclosure100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FairValueInputsLevel3, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302017-12-312015-12-312015-06-272014-06-28
Value13111312121516162217017
Percentage of LiabilitiesFairValueDisclosure94.9141.7269.4336.1213.8166.3248.5178.0578.9426.20.0191.2

us-gaap:DebtInstrument

us-gaap:LineOfCredit

prgo:A2018Revolver



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-31
Value1000032500000
Percentage of LineOfCredit100.00.00.0100.00.00.00.00.00.0

us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding



Period End2020-03-282019-12-312019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012016-12-312015-12-312015-06-272015-03-282014-12-272014-09-272014-06-28
Value207300001600030000000
Percentage of LineOfCreditFacilityFairValueOfAmountOutstanding100.00.0100.00.00.00.00.0100.0100.00.00.00.0100.00.00.00.00.00.0

us-gaap:DebtInstrument

us-gaap:LoansPayable

prgo:A2019EuroDenominatedTermLoandueAugust152022



Period End2020-03-282019-12-312019-09-282018-12-31
Value6006006000
Percentage of LoansPayable100.0100.0100.00.0

us-gaap:OperatingLeaseLiability



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302019-01-01
Value127133135140151166
Percentage of OperatingLeaseLiability100.0100.0100.0100.0100.0100.0

us-gaap:StatementBusinessSegments

prgo:ConsumerSelfCareAmericas



Period End2020-03-282019-12-312019-09-282019-06-292019-03-30
Value2122232230
Percentage of OperatingLeaseLiability16.817.117.316.320.0

prgo:ConsumerSelfCareInternational



Period End2020-03-282019-12-312019-09-282019-06-292019-03-30
Value4042414244
Percentage of OperatingLeaseLiability31.631.730.430.629.4

prgo:RXPharmaceuticals



Period End2020-03-282019-12-312019-09-282019-06-292019-03-30
Value3436373840
Percentage of OperatingLeaseLiability27.227.227.727.726.5

us-gaap:MaterialReconcilingItems



Period End2020-03-282019-12-312019-09-282019-06-292019-03-30
Value3132333536
Percentage of OperatingLeaseLiability24.424.124.625.424.1

us-gaap:BalanceSheetLocation

us-gaap:OperatingLeaseLiabilityCurrent

us-gaap:AccruedLiabilities



Period End2020-03-282019-12-31
Value3032
Percentage of OperatingLeaseLiabilityCurrent100.0100.0

us-gaap:BalanceSheetLocation

us-gaap:OperatingLeaseLiabilityNoncurrent

us-gaap:OtherNoncurrentLiabilities



Period End2020-03-282019-12-31
Value96101
Percentage of OperatingLeaseLiabilityNoncurrent100.0100.0

us-gaap:OtherLongTermDebt



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-06-29
Value2724248762335112233446586662238867
Percentage of OtherLongTermDebt100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:PreferredStockParOrStatedValuePerShare



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-06-29
Value0.00010.00010.00010.00010.00010.00010.00010.00010.00010.00010.00010.00010.00010.00010.00010.00010.00010.00010.00010.00010.00010.00010.00010.00010.00.00.0
Percentage of PreferredStockParOrStatedValuePerShare100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.00.0

us-gaap:RestructuringReserve



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282013-12-282013-09-282013-06-292012-06-302011-06-25
Value1619212420242912122126395114101213201133316143210
Percentage of RestructuringReserve100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0

us-gaap:SeniorNotes



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-11-082013-06-29
Value2750275127472753288628922896289829142906325532345383537354265918593746984722472038903890229422942293229322791561
Percentage of SeniorNotes100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DebtInstrument

prgo:A3.500UnsecuredSeniornotesdueMarch152021



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312016-12-312015-06-27
Value2802802802802802802802802802805000
Percentage of SeniorNotes10.210.210.210.29.79.79.79.79.69.69.30.0

prgo:A3.5SeniornotedueDecember152021



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022015-12-312015-06-27
Value309309309309309309309309309309309309500500500500500500
Percentage of SeniorNotes11.311.311.311.210.710.710.710.710.610.79.59.69.39.39.28.410.610.6

prgo:A4.00UnsecuredSeniorNotesdueNovember152023



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-06-27
Value215215215215215215215215215215215215800800800800800800800
Percentage of SeniorNotes7.87.87.87.87.57.57.47.47.47.46.66.714.914.914.713.513.517.016.9

prgo:A4.375seniornotedueMarch152026



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-06-27
Value70070070070070070070070070070070070070070070070070000
Percentage of SeniorNotes25.425.425.525.424.324.224.224.224.024.121.521.613.013.012.911.811.80.00.0

prgo:A4.9SeniorLoandue2044



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-06-27
Value303303303303303303303303303303303303400400400400400400400
Percentage of SeniorNotes11.011.011.111.010.510.510.510.510.410.59.39.47.47.47.46.86.78.58.5

prgo:A5.105SeniornotedueJuly282023



Period End2020-03-282019-12-312019-09-282019-06-292018-12-31
Value150151147153154
Percentage of SeniorNotes5.55.55.45.65.4

prgo:A5.30UnsecuredSeniorNotesdueNovember152043



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-06-27
Value909090909090909090909090400400400400400400400
Percentage of SeniorNotes3.33.33.33.33.13.13.13.13.13.12.82.87.47.47.46.86.78.58.5

us-gaap:DebtInstrument, us-gaap:FairValueByFairValueHierarchyLevel

prgo:PublicBondsandPrivatePlacement, us-gaap:FairValueInputsLevel1



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312016-12-312015-12-31
Value248226182604253324722316251325252600270046003800
Percentage of SeniorNotes90.395.294.892.085.780.186.887.289.292.985.680.9

us-gaap:DebtInstrument, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementBasis

prgo:PublicBondsandPrivatePlacement, us-gaap:FairValueInputsLevel1, us-gaap:CarryingReportedAmountFairValueDisclosure



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312016-12-312015-12-31
Value260026002600260026002600260026002600260046003900
Percentage of SeniorNotes94.594.594.694.490.189.989.889.789.289.585.683.0

us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest



Period End2020-03-282019-12-312019-09-282019-06-292019-03-302018-12-312018-09-292018-06-302018-03-312017-12-312017-09-302017-07-012017-04-012016-12-312016-10-012016-07-022016-04-022015-12-312015-09-262015-06-272015-03-282014-12-272014-09-272014-06-282014-03-292013-12-282013-09-282013-06-29
Value57865804575957265700566856605897620561706041608160675957867198999846100361073210662958597158716869385588501-160
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Line plots across dimensions of each concept

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:StatementBusinessSegments


us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:ProductOrService, us-gaap:StatementBusinessSegments


us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:ProductOrService, us-gaap:StatementBusinessSegments


us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:StatementGeographical


us-gaap:OperatingIncomeLoss us-gaap:StatementBusinessSegments


us-gaap:Assets us-gaap:StatementBusinessSegments


us-gaap:StockholdersEquity us-gaap:StatementEquityComponents


us-gaap:Goodwill us-gaap:StatementBusinessSegments


us-gaap:Goodwill us-gaap:BusinessAcquisition, us-gaap:StatementBusinessSegments


us-gaap:StockholdersEquity us-gaap:StatementEquityComponents